Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
44000,,5079186,CHEMBL1614675,Clearance in rat after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,CL,mL.min-1.kg-1,43.0,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,43.0
44001,,5080460,CHEMBL1614672,Fraction unbound in human after iv administration,A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311056,=,1,1,=,Fu,,0.6,CHEMBL3879801,,NON-PROTEIN TARGET,,,fu,,,0.6
44002,,5081195,CHEMBL1614670,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311056,=,1,1,=,Vdss,L.kg-1,1.4,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,1.4
44003,,5081534,CHEMBL1614682,Volume of distribution at steady state in human after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,Vdss,L.kg-1,2.0,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,2.0
44004,,5081619,CHEMBL1614681,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,CL,mL.min-1.kg-1,2.2,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,2.2
44005,,5081708,CHEMBL1614671,Clearance in human after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311056,=,1,1,=,CL,mL.min-1.kg-1,2.4,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,2.4
44006,,5081831,CHEMBL1614678,Volume of distribution at steady state in dog after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,Vdss,L.kg-1,2.7,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,2.7
44007,,5082067,CHEMBL1614676,Volume of distribution at steady state in rat after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,0,=,Vdss,mL/min/kg,3.6,CHEMBL612558,,ADMET,,,Vdss,mL/min/kg,,3.6
44008,,5082088,CHEMBL1614677,Clearance in dog after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,CL,mL.min-1.kg-1,3.7,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,3.7
44009,,5082331,CHEMBL1614680,Volume of distribution at steady state in monkey after iv administration,A,BAO_0003041,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,Vdss,L.kg-1,4.9,CHEMBL612558,,ADMET,,,Vdss,L/kg,UO_0000197,4.9
44010,,5082736,CHEMBL1614674,Half life in human after iv administration,A,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614632,Drug Metab Dispos,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1311056,=,1,1,=,T1/2,hr,8.2,CHEMBL612558,,ADMET,,,t1/2,h,UO_0000032,8.2
44011,,5083047,CHEMBL1614679,Clearance in monkey after iv administration,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1614629,J Pharm Sci,2005.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1311057,=,1,1,=,CL,mL.min-1.kg-1,12.0,CHEMBL612558,,ADMET,,,CL,mL/min/kg,,12.0
44012,,5085044,CHEMBL1636920,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44013,,5085045,CHEMBL1636918,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44014,,5085046,CHEMBL1636911,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44015,,5085052,CHEMBL1636919,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
44016,,5085067,CHEMBL1636909,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
44017,,5085068,CHEMBL1636908,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,1.0
44018,,5085080,CHEMBL1636916,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44019,,5085081,CHEMBL1636915,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44020,,5085082,CHEMBL1636912,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44021,,5085083,CHEMBL1636910,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44022,,5085084,CHEMBL1636907,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44023,,5085085,CHEMBL1636906,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44024,,5085091,CHEMBL1636914,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44025,,5085092,CHEMBL1636913,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44026,,5085093,CHEMBL1636905,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44027,,5085094,CHEMBL1636904,Antibacterial activity against Streptococcus pneumoniae R6 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44028,,5085095,CHEMBL1636903,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44029,,5086040,CHEMBL1635036,Antimicrobial activity against Nocardia brasiliensis HUJEG-1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629568,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1313911,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612976,Nocardia brasiliensis,Nocardia brasiliensis,37326.0,,MIC,ug ml-1,UO_0000274,0.25
44030,,5091201,CHEMBL1637207,Antibacterial activity against Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.25
44031,,5091202,CHEMBL1637208,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.125
44032,,5091203,CHEMBL1637209,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.125
44033,,5091204,CHEMBL1637210,Antibacterial activity against hospital acquired methicillin-resistant Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
44034,,5091205,CHEMBL1637211,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
44035,,5091206,CHEMBL1637212,Antibacterial activity against quinolone-resistant Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
44036,,5091207,CHEMBL1637213,Antibacterial activity against vancomycin-susceptible methicillin-resistant Staphylococcus aureus 32 harboring GyrA S84L and GrlA S80Y mutant after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
44037,,5091208,CHEMBL1637214,Antibacterial activity against vancomycin-susceptible methicillin-resistant Staphylococcus aureus 34 harboring GyrA S84L and GrlA S80F mutant after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
44038,,5091209,CHEMBL1637215,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu3 harboring GyrA S84L and GrlA S80F mutant after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
44039,,5091210,CHEMBL1637216,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus Mu50 harboring GyrA S84L and GrlA S80F mutant after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
44040,,5091211,CHEMBL1637217,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS1 harboring GyrA S84L and GrlA S80F mutant after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
44041,,5091212,CHEMBL1637218,Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS2 harboring GyrA S84L and GrlA S80F mutant after 24 hrs by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
44042,,5091213,CHEMBL1637219,"Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS3 harboring GyrA S84L and GrlA S80F, E84K mutant after 24 hrs by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
44043,,5091214,CHEMBL1637220,"Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS5 harboring GyrA S84L, E88K and GrlA S80F, E84G mutant after 24 hrs by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,>,1,1,>,MIC,ug.mL-1,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,32.0
44044,,5091215,CHEMBL1637221,"Antibacterial activity against vancomycin-resistant Staphylococcus aureus VRS6 harboring GyrA S84L and GrlA S80F, E84G mutant after 24 hrs by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
44045,,5091246,CHEMBL1637207,Antibacterial activity against Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
44046,,5091247,CHEMBL1637208,Antibacterial activity against methicillin-susceptible Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,2.0
44047,,5091248,CHEMBL1637209,Antibacterial activity against community acquired methicillin-resistant Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,2.0
44048,,5091249,CHEMBL1637210,Antibacterial activity against hospital acquired methicillin-resistant Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
44049,,5091250,CHEMBL1637211,Antibacterial activity against vancomycin-intermediate Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
44050,,5091251,CHEMBL1637212,Antibacterial activity against quinolone-resistant Staphylococcus aureus after 24 hrs by CLSI method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629623,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1315128,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,16.0
44051,,5095543,CHEMBL1633651,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as increase in mouse survival at 50 mg/kg, ip administered 36 hrs postinfection as single dose",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1314737,=,1,1,=,TIME,hr,24.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Time,hr,UO_0000032,24.0
44052,,5095544,CHEMBL1633652,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as increase in mouse survival at 50 mg/kg, ip administered 36 hrs postinfection every 12 hrs for 5 days",F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1314737,=,1,0,=,Activity,%,100.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,%,UO_0000187,100.0
44053,,5095545,CHEMBL1633653,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as log reduction in bacterial CFU per ml of blood at 50 mg/kg, ip administered 36 hrs postinfection as single dose measured within 1 hr",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,=,1,0,=,FC,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,FC,,,1.0
44054,,5095546,CHEMBL1633654,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as log reduction in bacterial CFU in brain at 50 mg/kg, ip administered 36 hrs postinfection as single dose measured within 1 hr",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,=,1,0,=,FC,,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,FC,,,1.0
44055,Active,5095547,CHEMBL1633655,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as reduction in bacterial count in spleen at 50 mg/kg, ip administered 36 hrs postinfection as single dose measured within 1 hr",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
44056,Active,5095548,CHEMBL1633656,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as reduction in bacterial count in liver at 50 mg/kg, ip administered 36 hrs postinfection as single dose measured within 1 hr",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
44057,,5095552,CHEMBL1633660,Ratio of AUC (24 hrs) in plasma in Listeria monocytogenes EGD-e infected BALB/c mouse to MIC for Listeria monocytogenes EGD-e,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,=,1,0,=,RatioAUC/MIC,,54.0,CHEMBL612545,,Unchecked,,,RatioAUC/MIC,,,54.0
44058,Active,5095553,CHEMBL1633662,"Antibacterial activity against Listeria monocytogenes EGD-e in BALB/c mouse central nervous system listeriosis model assessed as mouse survival at 50 mg/kg, ip administered 36 hrs postinfection every 12 hrs for 5 days measured after 2 months",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
44059,,5095562,CHEMBL1633661,Ratio of Cmax in plasma in Listeria monocytogenes EGD-e infected BALB/c mouse to MIC for Listeria monocytogenes EGD-e,F,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629550,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1314737,=,1,0,=,Ratio,,34.0,CHEMBL612545,,Unchecked,,,Ratio,,,34.0
44060,,5096770,CHEMBL1636732,Antimicrobial activity against Staphylococcus epidermidis Xen 43 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1312946,=,1,0,=,log10cfu,,-0.41,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,-0.41
44061,,5096778,CHEMBL1636728,Antimicrobial activity against Staphylococcus aureus Xen 30 biofilm assessed as log10 CFU/cm'2 in bacterial count,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1312946,=,1,0,=,log10cfu,,1.33,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,1.33
44062,,5096785,CHEMBL1636733,Antimicrobial activity against Staphylococcus epidermidis Xen 43 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 2000 microamperes of electric current by bioelectric effect assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1312946,=,1,0,=,log10cfu,,2.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,log10cfu,,,2.5
44063,,5096794,CHEMBL1636731,Antimicrobial activity against Staphylococcus aureus Xen 30 biofilm assessed as log10 CFU/cm'2 in bacterial count in presence of 20 microamperes of electric current by bioelectric effect assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1312946,=,1,0,=,log10cfu,,2.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,2.1
44064,,5096808,CHEMBL1636724,Antimicrobial activity against Staphylococcus epidermidis Xen 43 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312946,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
44065,,5096816,CHEMBL1635872,Antimicrobial activity against Staphylococcus aureus Xen 30 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629558,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312946,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
44066,,5096855,CHEMBL1636746,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,31.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,31.0
44067,,5096857,CHEMBL1636744,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,28.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,28.0
44068,,5096858,CHEMBL1636737,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,28.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,28.0
44069,,5096859,CHEMBL1636747,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,27.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,27.0
44070,,5096860,CHEMBL1636739,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,27.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,27.0
44071,,5096862,CHEMBL1636745,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,26.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,26.0
44072,,5096863,CHEMBL1636742,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,26.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,26.0
44073,,5096864,CHEMBL1636736,Antibacterial activity against Streptococcus pneumoniae R6 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,26.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,26.0
44074,,5096865,CHEMBL1636735,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,26.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,26.0
44075,,5096869,CHEMBL1636748,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,25.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,25.0
44076,,5096870,CHEMBL1636741,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,25.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,25.0
44077,,5096871,CHEMBL1636740,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,25.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,25.0
44078,,5096877,CHEMBL1636738,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,24.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,24.0
44079,,5096898,CHEMBL1636900,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
44080,,5096899,CHEMBL1636743,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,21.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,21.0
44081,,5096919,CHEMBL1636901,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,18.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,18.0
44082,,5096920,CHEMBL1636899,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,18.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,18.0
44083,,5096923,CHEMBL1636902,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,17.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,17.0
44084,,5096941,CHEMBL1636749,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar disk diffusion method,F,BAO_0003039,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Millimeter,1312955,=,1,1,=,IZ,mm,12.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,DIZ,mm,UO_0000016,12.0
44085,,5096955,CHEMBL1636921,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
44086,,5096956,CHEMBL1636917,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1629559,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1312955,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,8.0
44087,,5140704,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44088,,5140718,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44089,,5140732,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44090,,5140748,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44091,,5140763,CHEMBL1666068,Antimicrobial activity against Streptococcus pneumoniae 1 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44092,,5140778,CHEMBL1666069,Antimicrobial activity against Streptococcus pneumoniae 2 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44093,,5140793,CHEMBL1666070,Antimicrobial activity against Streptococcus pneumoniae 3 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44094,,5140808,CHEMBL1666071,Antimicrobial activity against Streptococcus pneumoniae 4 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
44095,,5140823,CHEMBL1666072,Antimicrobial activity against Streptococcus pneumoniae 5 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44096,,5140838,CHEMBL1666073,Antimicrobial activity against Streptococcus pneumoniae 6 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44097,,5140853,CHEMBL1666074,Antimicrobial activity against Streptococcus pneumoniae 7 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44098,,5140868,CHEMBL1666075,Antimicrobial activity against Streptococcus pneumoniae 8 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44099,,5140883,CHEMBL1666076,Antimicrobial activity against Streptococcus pneumoniae 9 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44100,,5140898,CHEMBL1666077,Antimicrobial activity against Streptococcus pneumoniae 10 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44101,,5140913,CHEMBL1666078,Antimicrobial activity against Streptococcus pneumoniae 11 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44102,,5141983,CHEMBL1666079,Antimicrobial activity against Streptococcus pneumoniae 12 by time-kill analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44103,,5141999,CHEMBL1666080,Antimicrobial activity against Streptococcus pneumoniae isolate 24 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44104,,5142014,CHEMBL1666081,Antimicrobial activity against Streptococcus pneumoniae isolate 33 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44105,,5142029,CHEMBL1666082,Antimicrobial activity against Streptococcus pneumoniae isolate 37 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44106,,5142044,CHEMBL1666083,Antimicrobial activity against Streptococcus pneumoniae isolate 1055 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44107,,5142062,CHEMBL1666229,Antimicrobial activity against Streptococcus pneumoniae isolate 1394 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44108,,5142077,CHEMBL1666230,Antimicrobial activity against Streptococcus pneumoniae isolate 1397 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44109,,5142092,CHEMBL1666231,Antimicrobial activity against Streptococcus pneumoniae isolate 1424 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44110,,5142107,CHEMBL1666232,Antimicrobial activity against Streptococcus pneumoniae isolate 1564 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44111,,5142122,CHEMBL1666233,Antimicrobial activity against Streptococcus pneumoniae isolate 2617 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44112,,5142137,CHEMBL1666234,Antimicrobial activity against Streptococcus pneumoniae isolate 2686 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44113,,5142152,CHEMBL1666235,Antimicrobial activity against Streptococcus pneumoniae isolate 2688 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44114,,5142167,CHEMBL1666236,Antimicrobial activity against Streptococcus pneumoniae isolate 2874 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44115,,5142182,CHEMBL1666237,Antimicrobial activity against Streptococcus pneumoniae isolate 2880 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44116,,5142197,CHEMBL1666238,Antimicrobial activity against Streptococcus pneumoniae isolate 3260 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44117,,5142212,CHEMBL1666240,Antimicrobial activity against Streptococcus pneumoniae isolate 3275 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44118,,5142227,CHEMBL1666241,Antimicrobial activity against Streptococcus pneumoniae isolate 3282 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44119,,5142242,CHEMBL1666242,Antimicrobial activity against Streptococcus pneumoniae isolate 3346 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44120,,5142257,CHEMBL1666243,Antimicrobial activity against Streptococcus pneumoniae isolate 3374 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44121,,5142272,CHEMBL1666244,Antimicrobial activity against Streptococcus pneumoniae isolate 3412 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44122,,5142287,CHEMBL1666245,Antimicrobial activity against Streptococcus pneumoniae isolate 3455 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44123,,5142302,CHEMBL1666246,Antimicrobial activity against Streptococcus pneumoniae isolate 3458 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44124,,5142317,CHEMBL1666247,Antimicrobial activity against Streptococcus pneumoniae isolate 3481 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44125,,5143385,CHEMBL1666248,Antimicrobial activity against Streptococcus pneumoniae isolate 3587 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44126,,5143400,CHEMBL1666249,Antimicrobial activity against Streptococcus pneumoniae isolate 3681 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44127,,5143415,CHEMBL1666250,Antimicrobial activity against Streptococcus pneumoniae isolate 3791 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44128,,5143430,CHEMBL1666251,Antimicrobial activity against Streptococcus pneumoniae isolate 4747 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44129,,5143445,CHEMBL1666252,Antimicrobial activity against Streptococcus pneumoniae isolate 4755 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44130,,5143473,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
44131,,5143487,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.125
44132,,5143501,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
44133,,5143515,CHEMBL1666060,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
44134,,5143529,CHEMBL1666061,Antimicrobial activity against penicillin-intermediate Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
44135,,5143543,CHEMBL1666062,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44136,,5143562,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
44137,,5143576,CHEMBL1666066,Antimicrobial activity against Streptococcus pneumoniae 19A by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
44138,,5143626,CHEMBL1666084,Antimicrobial activity against Streptococcus pneumoniae isolate 1146 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,2.0
44139,,5143627,CHEMBL1666227,Antimicrobial activity against Streptococcus pneumoniae isolate 1147 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44140,,5143628,CHEMBL1666228,Antimicrobial activity against Streptococcus pneumoniae isolate 1384 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44141,,5143629,CHEMBL1666239,Antimicrobial activity against Streptococcus pneumoniae isolate 3263 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649446,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326387,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
44142,,5148904,CHEMBL1662448,"fAUC/MIC in osteomyelitis patient serum at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 1 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,15.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,15.0
44143,,5148905,CHEMBL1662449,"fAUC/MIC in osteomyelitis patient cortical bone at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 1 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,13.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,13.0
44144,,5148906,CHEMBL1662450,"fAUC/MIC in osteomyelitis patient cancellous bone at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 1 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,13.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,13.0
44145,,5148907,CHEMBL1662451,Antimicrobial activity against Staphylococcus aureus,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326023,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,mg/L,UO_0000274,0.125
44146,,5148908,CHEMBL1662452,"fAUC/MIC in osteomyelitis patient serum at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 0.375 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,40.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,40.0
44147,,5148909,CHEMBL1662453,"fAUC/MIC in osteomyelitis patient cortical bone at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 0.5 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,33.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,33.0
44148,,5148910,CHEMBL1662454,"fAUC/MIC in osteomyelitis patient cancellous bone at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 0.375 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,33.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,33.0
44149,,5148911,CHEMBL1662455,"fAUC/MIC in osteomyelitis patient serum at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 0.19 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,66.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,66.0
44150,,5148912,CHEMBL1662446,"fAUC/MIC in osteomyelitis patient cortical bone at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 0.25 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,55.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,55.0
44151,,5148913,CHEMBL1662447,"fAUC/MIC in osteomyelitis patient cancellous bone at 400 mg, po administered for every 24 hrs at PKPD breakpoint at 0.25 mg/liter",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,fAUC/MIC,,55.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,55.0
44152,,5148914,CHEMBL1662456,"Drug level in osteomyelitis patient cortical bone at 400 mg, po administered for every 24 hrs",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1326023,=,1,0,=,Drug uptake,%,80.0,CHEMBL612558,,ADMET,,,Drug uptake,%,UO_0000187,80.0
44153,,5148915,CHEMBL1662457,"Drug level in osteomyelitis patient cancellous bone at 400 mg, po administered for every 24 hrs",A,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1326023,=,1,0,=,Drug uptake,%,78.0,CHEMBL612558,,ADMET,,,Drug uptake,%,UO_0000187,78.0
44154,,5148924,CHEMBL1662466,"Ratio of drug level in cortical bone to serum in osteomyelitis patient at 400 mg, po administered for every 24 hrs by MAP-Bayesian method",A,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,Ratio,,0.803,CHEMBL612558,,ADMET,,,Ratio,,,0.803
44155,,5148925,CHEMBL1662467,"Ratio of drug level in cancellous bone to serum in osteomyelitis patient at 400 mg, po administered for every 24 hrs by MAP-Bayesian method",A,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,Ratio,,0.953,CHEMBL612558,,ADMET,,,Ratio,,,0.953
44156,,5148926,CHEMBL1662599,"Ratio of drug level in cortical bone to serum in osteomyelitis patient at 400 mg, po administered for every 24 hrs by by three stage hierarchical Bayesian method",A,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,Ratio,,1.01,CHEMBL612558,,ADMET,,,Ratio,,,1.01
44157,,5148927,CHEMBL1662600,"Ratio of drug level in cancellous bone to serum in osteomyelitis patient at 400 mg, po administered for every 24 hrs by by three stage hierarchical Bayesian method",A,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649178,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1326023,=,1,0,=,Ratio,,0.775,CHEMBL612558,,ADMET,,,Ratio,,,0.775
44158,,5154337,CHEMBL1662080,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,13.6,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,13.6
44159,,5154338,CHEMBL1662081,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM in presence of 100 uM of p-glycoprotein and MRP inhibitor verapamil,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,8.05,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,8.05
44160,,5154339,CHEMBL1662082,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM in presence of 3 uM P-gp inhibitor PSC-833,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,8.87,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,8.87
44161,,5154340,CHEMBL1662083,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM in presence of 100 uM of MRP inhibitor Probenecid,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,4.42,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,4.42
44162,,5154341,CHEMBL1662084,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM in presence of in presence of 10 uM of p-glycoprotein and MRP transport inducer rifampin,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,4.35,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,4.35
44163,,5154342,CHEMBL1662085,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM in presence of in presence of 25 uM of p-glycoprotein and MRP transport inducer rifampin,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,4.08,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,4.08
44164,,5154343,CHEMBL1662086,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM in presence of 100 uM of p-glycoprotein and MRP inhibitor verapamil,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,8.07,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,8.07
44165,,5155426,CHEMBL1662087,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM in presence of 3 uM P-gp inhibitor PSC-833,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,7.74,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,7.74
44166,,5155427,CHEMBL1662088,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM in presence of 100 uM of MRP inhibitor Probenecid,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,9.58,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,9.58
44167,,5155428,CHEMBL1662089,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM in presence of in presence of 10 uM of p-glycoprotein and MRP transport inducer rifampin,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,11.86,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,11.86
44168,,5155429,CHEMBL1662090,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM in presence of in presence of 25 uM of p-glycoprotein and MRP transport inducer rifampin,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,12.48,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,12.48
44169,,5155430,CHEMBL1662091,P-glycoprotein-mediated transport in human Calu3 cells assessed as efflux ratio of permeability from apical to basolateral side over basolateral to apical side at 50 uM in presence of 100 uM of p-glycoprotein and MRP inhibitor verapamil,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,1.0,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,1.0
44170,,5155431,CHEMBL1662092,P-glycoprotein-mediated transport in human Calu3 cells assessed as efflux ratio of permeability from apical to basolateral side over basolateral to apical side at 50 uM in presence of 3 uM of p-glycoprotein transport inhibitor PSC-833,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,0.9,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,0.9
44171,,5155432,CHEMBL1662093,P-glycoprotein-mediated transport in human Calu3 cells assessed as efflux ratio of permeability from apical to basolateral side over basolateral to apical side at 50 uM in presence of 100 uM of MRP inhibitor Probenecid,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,2.2,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,2.2
44172,,5155433,CHEMBL1662919,P-glycoprotein-mediated transport in human Calu3 cells assessed as efflux ratio of permeability from apical to basolateral side over basolateral to apical side at 50 uM in presence of 10 uM of p-glycoprotein and MRP transport inducer rifampin,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,2.7,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,2.7
44173,,5155434,CHEMBL1662920,P-glycoprotein-mediated transport in human Calu3 cells assessed as efflux ratio of permeability from apical to basolateral side over basolateral to apical side at 50 uM in presence of 25 uM of p-glycoprotein and MRP transport inducer rifampin,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,3.1,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,3.1
44174,,5155435,CHEMBL1662921,Apparent passive permeability across human Calu3 cells at < 10 ug/ml,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,13.6,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,13.6
44175,,5155437,CHEMBL1662923,Activity at P-glycoprotein in human Calu3 cells,A,BAO_0000477,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325739,=,1,0,=,Km,ug ml-1,64.6,CHEMBL612558,,ADMET,,,Km,ug ml-1,UO_0000274,64.6
44176,,5155438,CHEMBL1662924,Apparent passive permeability across human Calu3 cells at 350 ug/ml,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,7.9,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,7.9
44177,,5155439,CHEMBL1662925,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side by measuring compound level at 50 uM after 180 mins,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,microg/cm2,2.49,CHEMBL612558,,ADMET,,,Papp,microg/cm2,,2.49
44178,,5155440,CHEMBL1662926,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side by measuring compound level at 50 uM after 180 mins,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,microg/cm3,1.22,CHEMBL612558,,ADMET,,,Papp,microg/cm3,,1.22
44179,,5155441,CHEMBL1662927,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as minimum apparent permeability from basolateral to apical side,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,7.9,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,7.9
44180,tde,5155442,CHEMBL1662928,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,,1,0,,Papp,,,CHEMBL612558,,ADMET,,,Papp,,,
44181,tde,5155443,CHEMBL1662929,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,,1,0,,Papp,,,CHEMBL612558,,ADMET,,,Papp,,,
44182,,5155444,CHEMBL1662930,P-glycoprotein-mediated transport in human Calu3 cells assessed as efflux ratio of permeability from apical to basolateral side over basolateral to apical side at 50 uM,A,BAO_0000193,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Ratio,,2.0,CHEMBL612558,,ADMET,,,Ratio,,,2.0
44183,,5155445,CHEMBL1662928,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from apical to basolateral side at 50 uM,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,5.25,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,5.25
44184,,5155446,CHEMBL1662929,P-glycoprotein-mediated transport in human Calu3 cells expressing P-glycoprotein assessed as maximum apparent permeability from basolateral to apical side at 50 uM,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649150,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325739,=,1,0,=,Papp,10'-6 cm/s,10.53,CHEMBL612558,,ADMET,,,Papp,10'-6 cm/s,,10.53
44185,,5156381,CHEMBL1666604,Antimicrobial activity against Clostridium difficile C253 expressing tcdA and tcdB gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
44186,,5156382,CHEMBL1666605,"Antimicrobial activity against Clostridium difficile CD25 expressing tcdA, tcdB gene and GyrB Ser416Ala mutant by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
44187,,5156383,CHEMBL1666606,Antimicrobial activity against Clostridium difficile A422 expressing tcdA and tcdB gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
44188,,5156384,CHEMBL1666607,Antimicrobial activity against Clostridium difficile 630 expressing tcdA and tcdB gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
44189,,5156385,CHEMBL1667325,Antimicrobial activity against Clostridium difficile BI2 by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
44190,,5156386,CHEMBL1667331,Antimicrobial activity against Clostridium difficile C253a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44191,,5156387,CHEMBL1667332,Antimicrobial activity against Clostridium difficile C253b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44192,,5156388,CHEMBL1667333,Antimicrobial activity against Clostridium difficile C253c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44193,,5156389,CHEMBL1667337,Antimicrobial activity against Clostridium difficile C253d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44194,,5156390,CHEMBL1667459,Antimicrobial activity against Clostridium difficile C253e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44195,,5156391,CHEMBL1667460,Antimicrobial activity against Clostridium difficile C253f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44196,,5156392,CHEMBL1667464,Antimicrobial activity against Clostridium difficile C253g harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44197,,5156393,CHEMBL1667465,Antimicrobial activity against Clostridium difficile C253h harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44198,,5156394,CHEMBL1667466,Antimicrobial activity against Clostridium difficile C253i harboring GyrA Ala118Ser mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44199,,5156395,CHEMBL1667470,Antimicrobial activity against Clostridium difficile CD5a harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44200,,5156396,CHEMBL1667471,Antimicrobial activity against Clostridium difficile CD5b harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44201,,5156397,CHEMBL1667472,Antimicrobial activity against Clostridium difficile CD5c harboring GyrB Ser416Ala mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44202,,5156398,CHEMBL1667476,Antimicrobial activity against Clostridium difficile CD5d harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44203,,5156399,CHEMBL1667477,Antimicrobial activity against Clostridium difficile CD5e harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44204,,5156400,CHEMBL1667478,Antimicrobial activity against Clostridium difficile CD5f harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44205,,5156401,CHEMBL1667482,Antimicrobial activity against Clostridium difficile CD5 1-g harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44206,,5156402,CHEMBL1667483,Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44207,,5156403,CHEMBL1667484,Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala92Glu and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44208,,5156404,CHEMBL1667488,"Antimicrobial activity against Clostridium difficile CD5 2-g harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44209,,5156405,CHEMBL1667489,"Antimicrobial activity against Clostridium difficile CD5h harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44210,,5156406,CHEMBL1667490,"Antimicrobial activity against Clostridium difficile CD5i harboring GyrA Ala118Ser, Thr82Ala and GyrB Ser416Ala mutant genes selected after 8 ug/ml of moxifloxacin by agar dilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44211,,5156407,CHEMBL1667494,Antimicrobial activity against Clostridium difficile A422a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44212,,5156408,CHEMBL1667495,Antimicrobial activity against Clostridium difficile A422b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44213,,5156409,CHEMBL1667496,Antimicrobial activity against Clostridium difficile A422c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44214,,5156410,CHEMBL1667627,Antimicrobial activity against Clostridium difficile A422d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44215,,5156411,CHEMBL1667628,Antimicrobial activity against Clostridium difficile A422e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44216,,5156412,CHEMBL1667629,Antimicrobial activity against Clostridium difficile A422f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44217,,5156413,CHEMBL1665591,Antimicrobial activity against Clostridium difficile A422g harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44218,,5156414,CHEMBL1665592,Antimicrobial activity against Clostridium difficile A422h harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44219,,5156415,CHEMBL1665593,Antimicrobial activity against Clostridium difficile A422i harboring GyrA Asp81Asn mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44220,,5156416,CHEMBL1665597,Antimicrobial activity against Clostridium difficile 630a selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44221,,5156417,CHEMBL1665598,Antimicrobial activity against Clostridium difficile 630b selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44222,,5156418,CHEMBL1665599,Antimicrobial activity against Clostridium difficile 630c selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44223,,5156419,CHEMBL1665603,Antimicrobial activity against Clostridium difficile 630d selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44224,,5156420,CHEMBL1665604,Antimicrobial activity against Clostridium difficile 630e selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44225,,5156421,CHEMBL1665605,Antimicrobial activity against Clostridium difficile 630f selected after 4 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44226,,5156422,CHEMBL1665609,Antimicrobial activity against Clostridium difficile 630g harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44227,,5156423,CHEMBL1665610,Antimicrobial activity against Clostridium difficile 630h harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44228,,5156424,CHEMBL1665611,Antimicrobial activity against Clostridium difficile 630i harboring GyrB Asp26Val mutant gene selected after 8 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44229,,5156425,CHEMBL1665615,Antimicrobial activity against Clostridium difficile BI2a harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44230,,5156426,CHEMBL1665616,Antimicrobial activity against Clostridium difficile BI2b harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44231,,5156427,CHEMBL1665617,Antimicrobial activity against Clostridium difficile BI2c harboring GyrB Arg447Lys mutant gene selected after 2 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,16.0
44232,,5156428,CHEMBL1665621,Antimicrobial activity against Clostridium difficile BI2d harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,128.0
44233,,5156429,CHEMBL1665755,Antimicrobial activity against Clostridium difficile BI2e harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,128.0
44234,,5156430,CHEMBL1665756,Antimicrobial activity against Clostridium difficile BI2f harboring GyrB Arg447Lys and Asp426Asn mutant gene selected after 32 ug/ml of moxifloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,128.0
44235,,5156431,CHEMBL1665760,Antimicrobial activity against Clostridium difficile C253A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44236,,5156432,CHEMBL1665761,Antimicrobial activity against Clostridium difficile C253B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44237,,5156433,CHEMBL1665762,Antimicrobial activity against Clostridium difficile C253C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44238,,5156434,CHEMBL1665766,Antimicrobial activity against Clostridium difficile C253D selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44239,,5156435,CHEMBL1665767,Antimicrobial activity against Clostridium difficile C253E selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44240,,5156436,CHEMBL1665768,Antimicrobial activity against Clostridium difficile C253F selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44241,,5156437,CHEMBL1665772,Antimicrobial activity against Clostridium difficile CD5A harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44242,,5156438,CHEMBL1665773,Antimicrobial activity against Clostridium difficile CD5B harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44243,,5156439,CHEMBL1665774,Antimicrobial activity against Clostridium difficile CD5C harboring GyrB Ser416Ala mutant gene selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44244,,5156440,CHEMBL1665778,Antimicrobial activity against Clostridium difficile CD5D harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44245,,5156441,CHEMBL1665779,Antimicrobial activity against Clostridium difficile CD5E harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44246,,5156442,CHEMBL1665780,Antimicrobial activity against Clostridium difficile CD5F harboring GyrB Ser416Ala mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44247,,5156443,CHEMBL1666642,Antimicrobial activity against Clostridium difficile A422A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44248,,5156444,CHEMBL1666643,Antimicrobial activity against Clostridium difficile A422B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44249,,5156445,CHEMBL1666644,Antimicrobial activity against Clostridium difficile A422C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44250,,5156446,CHEMBL1666648,Antimicrobial activity against Clostridium difficile A422D harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44251,,5156447,CHEMBL1666649,Antimicrobial activity against Clostridium difficile A422E harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44252,,5156448,CHEMBL1666650,Antimicrobial activity against Clostridium difficile A422F harboring GyrB Leu451Phe mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44253,,5156449,CHEMBL1666654,Antimicrobial activity against Clostridium difficile A422G harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
44254,,5156450,CHEMBL1666655,Antimicrobial activity against Clostridium difficile A422H harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
44255,,5156451,CHEMBL1666656,Antimicrobial activity against Clostridium difficile A422I harboring GyrA Thr82Ile and GyrB Leu451Phe mutant genes selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,256.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,256.0
44256,,5156452,CHEMBL1666660,Antimicrobial activity against Clostridium difficile 630A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44257,,5156453,CHEMBL1666661,Antimicrobial activity against Clostridium difficile 630B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44258,,5156454,CHEMBL1666662,Antimicrobial activity against Clostridium difficile 630C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44259,,5156455,CHEMBL1666666,Antimicrobial activity against Clostridium difficile 630D harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44260,,5156456,CHEMBL1666667,Antimicrobial activity against Clostridium difficile 630E harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44261,,5156457,CHEMBL1666668,Antimicrobial activity against Clostridium difficile 630F harboring GyrA Ala118Val mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44262,,5156458,CHEMBL1666672,Antimicrobial activity against Clostridium difficile BI2A selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44263,,5156459,CHEMBL1666673,Antimicrobial activity against Clostridium difficile BI2B selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44264,,5156460,CHEMBL1666674,Antimicrobial activity against Clostridium difficile BI2C selected after 4 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,4.0
44265,,5156461,CHEMBL1666678,Antimicrobial activity against Clostridium difficile BI2D harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
44266,,5156462,CHEMBL1666679,Antimicrobial activity against Clostridium difficile BI2E harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
44267,,5156463,CHEMBL1666680,Antimicrobial activity against Clostridium difficile BI2F harboring GyrB Glu466Lys mutant gene selected after 8 ug/ml of levofloxacin by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649483,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326703,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
44268,,5157371,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326308,<=,1,1,<=,MIC,ug.mL-1,0.007,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.007
44269,,5157381,CHEMBL1660791,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326308,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.06
44270,,5157391,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326308,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.03
44271,,5157401,CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326308,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,0.06
44272,,5158059,CHEMBL1655746,Antimicrobial activity against Bacteroides sp. in three-stage chemostat gut model assessed as log reduction in bacterial count at 43 mg/liter administered daily for 7 days,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,=,1,0,=,FC,,6.0,CHEMBL613908,Bacteroides sp.,Bacteroides sp.,29523.0,,FC,,,6.0
44273,,5158060,CHEMBL1655747,Antimicrobial activity against Enterococcus in three-stage chemostat gut model assessed as log reduction in bacterial count at 43 mg/liter administered daily for 7 days,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,=,1,0,=,FC,,6.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,FC,,,6.0
44274,,5158061,CHEMBL1655746,Antimicrobial activity against Bacteroides sp. in three-stage chemostat gut model assessed as log reduction in bacterial count at 43 mg/liter administered daily for 7 days,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,=,1,0,=,FC,,4.0,CHEMBL613908,Bacteroides sp.,Bacteroides sp.,29523.0,,FC,,,4.0
44275,Not Active,5158062,CHEMBL1655748,Antimicrobial activity against Bifidobacterium in three-stage chemostat gut model assessed as log reduction in bacterial count at 43 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44276,Not Active,5158063,CHEMBL1655749,Antimicrobial activity against Lactobacillus in three-stage chemostat gut model assessed as log reduction in bacterial count at 43 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44277,Not Active,5158064,CHEMBL1655750,Antimicrobial activity against Clostridium in three-stage chemostat gut model assessed as log reduction in bacterial count at 43 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44278,Active,5158071,CHEMBL1656246,Induction of cytotoxin production in Clostridium difficile PCR ribotype 027 in three-stage chemostat gut model at 43 mg/liter administered daily for 7 days measured after 2 days,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44279,Active,5158072,CHEMBL1656247,Induction of cytotoxin production in Clostridium difficile PCR ribotype 027 in three-stage chemostat gut model at 32 mg/liter,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44280,Active,5158073,CHEMBL1656248,Induction of cytotoxin production in Clostridium difficile PCR ribotype 001 in three-stage chemostat gut model at 43 mg/liter administered daily for 7 days,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44281,,5158076,CHEMBL1656239,Antimicrobial activity against Clostridium difficile PCR ribotype 027 after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325344,=,1,1,=,MIC,ug.mL-1,80.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,80.0
44282,,5158077,CHEMBL1656240,Antimicrobial activity against Clostridium difficile PCR ribotype 001 after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325344,=,1,1,=,MIC,ug.mL-1,80.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,80.0
44283,,5158079,CHEMBL1656245,Drug level in human feces,A,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1325344,=,1,0,=,Drug uptake,mg Kg-1,66.0,CHEMBL612558,,ADMET,,,Drug uptake,mg Kg-1,UO_0000308,66.0
44284,,5158083,CHEMBL1656241,Antimicrobial activity against Clostridium difficile PCR ribotype 027 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325344,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,32.0
44285,,5158084,CHEMBL1656242,Antimicrobial activity against Clostridium difficile PCR ribotype 001 expressing gyrB Glu466Lys mutant grown on fluoroquinolone-containing medium after 48 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649112,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325344,=,1,1,=,MIC,ug.mL-1,45.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,mg/L,UO_0000274,45.0
44286,,5159906,CHEMBL1653731,Antimicrobial activity against Enterobacter cloacae isolate 37 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
44287,,5159907,CHEMBL1653733,Antimicrobial activity against Enterobacter cloacae isolate 101 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
44288,,5159908,CHEMBL1653735,Antimicrobial activity against Enterobacter cloacae isolate 153 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.06
44289,,5159909,CHEMBL1653737,Antimicrobial activity against Escherichia coli isolate 17 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
44290,,5159910,CHEMBL1653739,Antimicrobial activity against Escherichia coli isolate 48 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
44291,,5159911,CHEMBL1653741,Antimicrobial activity against Klebsiella pneumoniae isolate 132 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
44292,,5159912,CHEMBL1653745,Antimicrobial activity against Klebsiella pneumoniae isolate 202 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
44293,,5159913,CHEMBL1653746,Antimicrobial activity against azide-resistant Escherichia coli J53,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
44294,,5159918,CHEMBL1653740,Antimicrobial activity against Klebsiella pneumoniae isolate 132 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.125
44295,,5159932,CHEMBL1653743,Antimicrobial activity against Klebsiella pneumoniae isolate 135 transconjugant expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
44296,,5159935,CHEMBL1653730,Antimicrobial activity against Enterobacter cloacae isolate 37 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,2.0
44297,,5159940,CHEMBL1653732,Antimicrobial activity against Enterobacter cloacae isolate 101 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,4.0
44298,,5159941,CHEMBL1653734,Antimicrobial activity against Enterobacter cloacae isolate 153 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,4.0
44299,,5159956,CHEMBL1653738,Antimicrobial activity against Escherichia coli isolate 48 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
44300,,5159957,CHEMBL1653744,Antimicrobial activity against Klebsiella pneumoniae isolate 202 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
44301,,5159990,CHEMBL1653736,Antimicrobial activity against Escherichia coli isolate 17 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
44302,,5159991,CHEMBL1653742,Antimicrobial activity against Klebsiella pneumoniae isolate 135 expressing aac(6')-Ib-cr gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649439,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326338,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
44303,,5162756,CHEMBL1665066,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44304,,5162757,CHEMBL1665067,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44305,,5162758,CHEMBL1665784,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44306,,5162759,CHEMBL1665785,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44307,,5162760,CHEMBL1665786,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44308,,5162761,CHEMBL1665787,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44309,,5162762,CHEMBL1665788,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44310,,5162763,CHEMBL1665789,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
44311,,5162802,CHEMBL1665931,Antibacterial activity against Streptococcus pneumoniae W001 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,0.5
44312,,5162803,CHEMBL1665932,Antibacterial activity against Streptococcus pneumoniae W002 harboring wild-type parC and gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,0.5
44313,,5162804,CHEMBL1665933,Antibacterial activity against Streptococcus pneumoniae S001 harboring parC Asp83Asn mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,4.0
44314,,5162805,CHEMBL1665934,Antibacterial activity against Streptococcus pneumoniae S002 harboring parC Ser79Phe mutant and wild-type gyrA genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,4.0
44315,,5162806,CHEMBL1665935,Antibacterial activity against Streptococcus pneumoniae S003 harboring wild-type parC and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,4.0
44316,,5162807,CHEMBL1665936,Antibacterial activity against Streptococcus pneumoniae S004 harboring wild-type parC and gyrA Gly85Asn mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,4.0
44317,,5162808,CHEMBL1665937,Antibacterial activity against Streptococcus pneumoniae D001 harboring parC Ser79Phe and gyrA Gly85Lys mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,16.0
44318,,5162809,CHEMBL1665938,Antibacterial activity against Streptococcus pneumoniae D002 harboring parC Ser79Phe and gyrA Ser81Phe mutant genes assessed as mutation prevention concentration after 48 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649531,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327010,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,ug ml-1,UO_0000274,16.0
44319,,5165453,CHEMBL1653973,Antimicrobial activity against Corynebacterium spp. by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,MIC90,ug ml-1,UO_0000274,8.0
44320,,5165462,CHEMBL1653975,Antimicrobial activity against Listeria monocytogenes by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,ug ml-1,UO_0000274,1.0
44321,,5165471,CHEMBL1653954,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1322882,=,1,0,=,Activity,%,92.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.0
44322,,5165480,CHEMBL1653956,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1322882,=,1,0,=,Activity,%,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,4.0
44323,,5165489,CHEMBL1653958,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1322882,=,1,0,=,Activity,%,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,8.0
44324,,5165498,CHEMBL1653960,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus assessed as susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1322882,=,1,0,=,Activity,%,0.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.0
44325,,5165507,CHEMBL1653962,Antimicrobial activity against Coagulase-negative Staphylococcus assessed as susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1322882,=,1,0,=,Activity,%,55.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,Activity,%,UO_0000187,55.0
44326,Not Determined,5165516,CHEMBL1653964,Antimicrobial activity against Group A Streptococcus assessed as susceptible isolates by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322882,,1,0,,Activity,,,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,Activity,,,
44327,Not Determined,5165525,CHEMBL1653966,Antimicrobial activity against Group B Streptococcus assessed as susceptible isolates by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322882,,1,0,,Activity,,,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,Activity,,,
44328,Not Determined,5165534,CHEMBL1653968,Antimicrobial activity against Group C Streptococcus assessed as susceptible isolates by agar dilution method,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322882,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44329,Not Determined,5165543,CHEMBL1653970,Antimicrobial activity against Group G Streptococcus assessed as susceptible isolates by agar dilution method,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322882,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44330,,5165552,CHEMBL1653972,Antimicrobial activity against Streptococcus pneumoniae assessed as susceptible isolates by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1322882,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44331,Not Determined,5165561,CHEMBL1653974,Antimicrobial activity against Corynebacterium spp. assessed as susceptible isolates by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322882,,1,0,,Activity,,,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,Activity,,,
44332,Not Determined,5165570,CHEMBL1653976,Antimicrobial activity against Listeria monocytogenes assessed as susceptible isolates by agar dilution method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322882,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
44333,,5166290,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.06
44334,,5166298,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.03
44335,,5166306,CHEMBL1667173,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
44336,,5166314,CHEMBL1665246,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
44337,,5166321,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC90,ug ml-1,UO_0000274,0.5
44338,,5166328,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,ug ml-1,UO_0000274,0.25
44339,Not Active,5166335,CHEMBL1667172,Antibacterial activity against Listeria monocytogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,Activity,,,
44340,,5166342,CHEMBL1665245,Antibacterial activity against Listeria monocytogenes by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,0.12
44341,,5166349,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,64.0
44342,,5166356,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,16.0
44343,Not Active,5166363,CHEMBL1667171,Antibacterial activity against vancomycin- resistant Enterococcus faecium assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,,,
44344,,5166370,CHEMBL1665244,Antibacterial activity against vancomycin- resistant Enterococcus faecium by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.12
44345,,5166377,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,16.0
44346,,5166384,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,0.25
44347,Not Active,5166391,CHEMBL1667170,Antibacterial activity against vancomycin- resistant Enterococcus faecalis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,,,
44348,,5166398,CHEMBL1665243,Antibacterial activity against vancomycin- resistant Enterococcus faecalis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.03
44349,,5166401,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
44350,,5166409,CHEMBL1667174,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,9.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,9.1
44351,,5166417,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
44352,,5166425,CHEMBL1665247,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus aureus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
44353,,5166433,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
44354,,5166441,CHEMBL1667175,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
44355,,5166449,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.06
44356,Not Active,5166457,CHEMBL1665248,Antibacterial activity against ciprofloxacin-susceptible and methicillin-resistant Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,MIC90,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,,,
44357,,5166465,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
44358,,5166473,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC,ug ml-1,UO_0000274,0.015
44359,,5166481,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC,ug ml-1,UO_0000274,0.03
44360,,5166489,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC,ug ml-1,UO_0000274,0.03
44361,,5166497,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC,ug ml-1,UO_0000274,0.03
44362,,5166505,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC,ug ml-1,UO_0000274,0.015
44363,,5167559,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,2.0
44364,,5167567,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC50,ug ml-1,UO_0000274,1.0
44365,,5167575,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC50,ug ml-1,UO_0000274,1.0
44366,,5167583,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC50,ug ml-1,UO_0000274,0.12
44367,,5167591,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC50,ug ml-1,UO_0000274,0.12
44368,,5167599,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC50,ug ml-1,UO_0000274,0.06
44369,Not Active,5167607,CHEMBL1665249,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,MIC90,,,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,,,
44370,,5167615,CHEMBL1665250,Antibacterial activity against Staphylococcus haemolyticus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,MIC90,ug ml-1,UO_0000274,8.0
44371,,5167623,CHEMBL1665251,Antibacterial activity against Staphylococcus hominis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,MIC90,ug ml-1,UO_0000274,4.0
44372,,5167631,CHEMBL1665252,Antibacterial activity against Staphylococcus lugdunensis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,MIC90,ug ml-1,UO_0000274,2.0
44373,,5167639,CHEMBL1665253,Antibacterial activity against Staphylococcus saprophyticus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,MIC90,ug ml-1,UO_0000274,0.12
44374,,5167647,CHEMBL1665254,Antibacterial activity against Staphylococcus warneri by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,MIC90,ug ml-1,UO_0000274,4.0
44375,,5167655,CHEMBL1667176,Antibacterial activity against non-ciprofloxacin-susceptible and methicillin-susceptible Staphylococcus epidermidis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,0.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,0.0
44376,,5167663,CHEMBL1667177,Antibacterial activity against Staphylococcus haemolyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,39.6,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,Activity,%,UO_0000187,39.6
44377,,5167671,CHEMBL1667178,Antibacterial activity against Staphylococcus hominis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,34.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,Activity,%,UO_0000187,34.0
44378,,5167679,CHEMBL1667179,Antibacterial activity against Staphylococcus lugdunensis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,73.3,CHEMBL613303,Staphylococcus lugdunensis,Staphylococcus lugdunensis,28035.0,,Activity,%,UO_0000187,73.3
44379,,5167687,CHEMBL1667180,Antibacterial activity against Staphylococcus saprophyticus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL613764,Staphylococcus saprophyticus,Staphylococcus saprophyticus,29385.0,,Activity,%,UO_0000187,100.0
44380,,5167695,CHEMBL1667181,Antibacterial activity against Staphylococcus warneri assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,76.0,CHEMBL612625,Staphylococcus warneri,Staphylococcus warneri,1292.0,,Activity,%,UO_0000187,76.0
44381,,5167703,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC,ug ml-1,UO_0000274,0.06
44382,,5167711,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
44383,,5167719,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC,ug ml-1,UO_0000274,0.03
44384,,5167727,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
44385,,5167735,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC50,ug ml-1,UO_0000274,0.12
44386,,5167743,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
44387,,5167751,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC50,ug ml-1,UO_0000274,0.12
44388,,5167759,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
44389,,5167767,CHEMBL1665255,Antibacterial activity against Streptococcus agalactiae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,MIC90,ug ml-1,UO_0000274,0.12
44390,,5167775,CHEMBL1665256,Antibacterial activity against Lancefield Streptococcus sp. 'group C' by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
44391,,5167783,CHEMBL1665257,Antibacterial activity against Lancefield Streptococcus sp. group F by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,MIC90,ug ml-1,UO_0000274,0.12
44392,,5167791,CHEMBL1665258,Antibacterial activity against Lancefield Streptococcus sp. 'group G' by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.12
44393,Not Active,5167799,CHEMBL1667182,Antibacterial activity against Streptococcus agalactiae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,Activity,,,
44394,Not Active,5167807,CHEMBL1667183,Antibacterial activity against Lancefield Streptococcus sp. 'group C' assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44395,Not Active,5167815,CHEMBL1667184,Antibacterial activity against Lancefield Streptococcus sp. group F assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614621,Streptococcus sp.,Streptococcus sp.,1306.0,,Activity,,,
44396,Not Active,5167823,CHEMBL1667185,Antibacterial activity against Lancefield Streptococcus sp. 'group G' assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44397,,5167831,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.03
44398,,5167838,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
44399,,5167845,CHEMBL1667186,Antibacterial activity against levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44400,,5167852,CHEMBL1667187,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,16.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,16.5
44401,,5167859,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.06
44402,,5167866,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
44403,,5167873,CHEMBL1665259,Antibacterial activity against levofloxacin-susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.12
44404,,5167880,CHEMBL1665260,Antibacterial activity against non-levofloxacin susceptible Streptococcus pneumoniae by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
44405,,5167887,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.06
44406,,5167895,CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
44407,,5168987,CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC,ug ml-1,UO_0000274,0.03
44408,,5168995,CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC,ug ml-1,UO_0000274,0.03
44409,,5169003,CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC,ug ml-1,UO_0000274,0.03
44410,,5169011,CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.03
44411,,5169019,CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC,ug ml-1,UO_0000274,0.03
44412,,5169027,CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC,ug ml-1,UO_0000274,0.03
44413,,5169035,CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC,ug ml-1,UO_0000274,0.03
44414,,5169043,CHEMBL1667188,Antibacterial activity against Streptococcus pyogenes assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,Activity,%,UO_0000187,0.12
44415,Not Active,5169051,CHEMBL1667189,Antibacterial activity against Streptococcus anginosus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,,,
44416,Not Active,5169059,CHEMBL1667190,Antibacterial activity against Streptococcus bovis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,Activity,,,
44417,Not Active,5169067,CHEMBL1667191,Antibacterial activity against Streptococcus constellatus assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,Activity,,,
44418,Not Active,5169075,CHEMBL1667192,Antibacterial activity against Streptococcus intermedius assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,Activity,,,
44419,Not Active,5169083,CHEMBL1667193,Antibacterial activity against Streptococcus mitis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,Activity,,,
44420,Not Active,5169091,CHEMBL1667194,Antibacterial activity against Streptococcus oralis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,Activity,,,
44421,Not Active,5169099,CHEMBL1667195,Antibacterial activity against Streptococcus salivarius assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,Activity,,,
44422,Not Active,5169107,CHEMBL1667196,Antibacterial activity against Streptococcus sanguinis assessed as percent susceptible isolates by CLSI M100-S18 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,Activity,,,
44423,,5169115,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.12
44424,,5169123,CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.12
44425,,5169131,CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC50,ug ml-1,UO_0000274,0.12
44426,,5169139,CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC50,ug ml-1,UO_0000274,0.12
44427,,5169147,CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC50,ug ml-1,UO_0000274,0.12
44428,,5169155,CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,ug ml-1,UO_0000274,0.12
44429,,5169163,CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC50,ug ml-1,UO_0000274,0.12
44430,,5169171,CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC50,ug ml-1,UO_0000274,0.12
44431,,5169179,CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC50,ug ml-1,UO_0000274,0.12
44432,,5169187,CHEMBL1665261,Antibacterial activity against Streptococcus pyogenes by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.25
44433,,5169195,CHEMBL1665262,Antibacterial activity against Streptococcus anginosus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.25
44434,,5169203,CHEMBL1665263,Antibacterial activity against Streptococcus bovis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613304,Streptococcus equinus,Streptococcus equinus,1335.0,,MIC90,ug ml-1,UO_0000274,0.25
44435,,5169211,CHEMBL1665264,Antibacterial activity against Streptococcus constellatus by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613151,Streptococcus constellatus,Streptococcus constellatus,76860.0,,MIC90,ug ml-1,UO_0000274,0.25
44436,,5169219,CHEMBL1665265,Antibacterial activity against Streptococcus intermedius by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL3301402,Streptococcus intermedius,Streptococcus intermedius,1338.0,,MIC90,ug ml-1,UO_0000274,0.25
44437,,5169227,CHEMBL1665266,Antibacterial activity against Streptococcus mitis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC90,ug ml-1,UO_0000274,0.25
44438,,5169235,CHEMBL1665267,Antibacterial activity against Streptococcus oralis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL613305,Streptococcus oralis,Streptococcus oralis,1303.0,,MIC90,ug ml-1,UO_0000274,0.25
44439,,5169243,CHEMBL1665268,Antibacterial activity against Streptococcus salivarius by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614620,Streptococcus salivarius,Streptococcus salivarius,1304.0,,MIC90,ug ml-1,UO_0000274,0.25
44440,,5169251,CHEMBL1665269,Antibacterial activity against Streptococcus sanguinis by CLSI M100-S18 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612314,Streptococcus sanguinis,Streptococcus sanguinis,1305.0,,MIC90,ug ml-1,UO_0000274,0.25
44441,,5169258,CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.03
44442,,5169265,CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC,ug ml-1,UO_0000274,0.015
44443,,5169272,CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,ug ml-1,UO_0000274,0.008
44444,,5169279,CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC,ug ml-1,UO_0000274,0.03
44445,,5169286,CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC50,ug ml-1,UO_0000274,8.0
44446,,5169293,CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC50,ug ml-1,UO_0000274,2.0
44447,,5169300,CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC50,ug ml-1,UO_0000274,0.06
44448,,5169307,CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC50,ug ml-1,UO_0000274,0.12
44449,,5169314,CHEMBL1665270,Antibacterial activity against Acinetobacter baumannii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC90,ug ml-1,UO_0000274,32.0
44450,,5170367,CHEMBL1665271,Antibacterial activity against Acinetobacter calcoaceticus by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,MIC90,ug ml-1,UO_0000274,8.0
44451,,5170374,CHEMBL1665272,Antibacterial activity against Acinetobacter lwoffii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC90,ug ml-1,UO_0000274,4.0
44452,,5170381,CHEMBL1665273,Antibacterial activity against Citrobacter freundii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,MIC90,ug ml-1,UO_0000274,4.0
44453,Not Active,5170388,CHEMBL1667197,Antibacterial activity against Acinetobacter baumannii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,,,
44454,Not Active,5170395,CHEMBL1667198,Antibacterial activity against Acinetobacter calcoaceticus assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614426,Acinetobacter calcoaceticus,Acinetobacter calcoaceticus,471.0,,Activity,,,
44455,Not Active,5170402,CHEMBL1667199,Antibacterial activity against Acinetobacter lwoffii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,Activity,,,
44456,,5170409,CHEMBL1667200,Antibacterial activity against Citrobacter freundii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,85.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,Activity,%,UO_0000187,85.0
44457,,5170416,CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC,ug ml-1,UO_0000274,0.015
44458,Not Active,5170424,CHEMBL1667201,Antibacterial activity against Citrobacter koseri assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,Activity,,,
44459,,5170432,CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC50,ug ml-1,UO_0000274,0.03
44460,,5170440,CHEMBL1665274,Antibacterial activity against Citrobacter koseri by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614438,Citrobacter koseri,Citrobacter koseri,545.0,,MIC90,ug ml-1,UO_0000274,0.25
44461,,5170449,CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC,ug ml-1,UO_0000274,0.03
44462,,5170456,CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC,ug ml-1,UO_0000274,0.015
44463,,5170463,CHEMBL1667202,Antibacterial activity against Enterobacter aerogenes assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,80.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,Activity,%,UO_0000187,80.0
44464,,5170470,CHEMBL1667203,Antibacterial activity against Enterobacter cloacae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,94.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,94.0
44465,,5170477,CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC50,ug ml-1,UO_0000274,0.12
44466,,5170484,CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC50,ug ml-1,UO_0000274,0.06
44467,,5170491,CHEMBL1665275,Antibacterial activity against Enterobacter aerogenes by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612508,Klebsiella aerogenes,Klebsiella aerogenes,548.0,,MIC90,ug ml-1,UO_0000274,16.0
44468,,5170498,CHEMBL1665276,Antibacterial activity against Enterobacter cloacae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,MIC90,ug ml-1,UO_0000274,2.0
44469,,5170505,CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.015
44470,,5170512,CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,1.0
44471,,5170519,CHEMBL1667204,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,0,=,Activity,ug ml-1,100.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,ug ml-1,UO_0000274,100.0
44472,,5170526,CHEMBL1667205,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,0,=,Activity,ug ml-1,9.1,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,Activity,ug ml-1,UO_0000274,9.1
44473,,5170533,CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.015,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,0.015
44474,,5170540,CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,8.0
44475,,5170547,CHEMBL1665277,Antibacterial activity against ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,0.06
44476,,5170554,CHEMBL1665278,Antibacterial activity against non-ciprofloxacin-susceptible Haemophilus influenzae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,16.0
44477,,5170561,CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC,ug ml-1,UO_0000274,0.03
44478,Not Active,5170569,CHEMBL1667206,Antibacterial activity against Klebsiella oxytoca assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,,,
44479,,5170577,CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC50,ug ml-1,UO_0000274,0.06
44480,,5170585,CHEMBL1665279,Antibacterial activity against Klebsiella oxytoca by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,MIC90,ug ml-1,UO_0000274,2.0
44481,,5170593,CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
44482,,5170600,CHEMBL1667207,Antibacterial activity against Klebsiella pneumoniae assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,90.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,90.0
44483,,5170607,CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC50,ug ml-1,UO_0000274,0.12
44484,,5170614,CHEMBL1665280,Antibacterial activity against Klebsiella pneumoniae by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC90,ug ml-1,UO_0000274,2.0
44485,,5170621,CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC,ug ml-1,UO_0000274,0.015
44486,,5170628,CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.015
44487,Not Active,5170636,CHEMBL1667208,Antibacterial activity against Legionella pneumophila assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,Activity,,,
44488,Not Active,5170643,CHEMBL1667209,Antibacterial activity against Moraxella catarrhalis assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,Activity,,,
44489,,5170651,CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC50,ug ml-1,UO_0000274,0.03
44490,,5170658,CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,0.03
44491,,5170666,CHEMBL1665281,Antibacterial activity against Legionella pneumophila by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL612505,Legionella pneumophila,Legionella pneumophila,446.0,,MIC90,ug ml-1,UO_0000274,0.06
44492,,5170673,CHEMBL1665282,Antibacterial activity against Moraxella catarrhalis by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.03,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,0.03
44493,,5170681,CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC,ug ml-1,UO_0000274,0.03
44494,Not Active,5170689,CHEMBL1667210,Antibacterial activity against Morganella morganii assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,Activity,,,
44495,,5170697,CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC50,ug ml-1,UO_0000274,0.25
44496,,5171747,CHEMBL1665283,Antibacterial activity against Morganella morganii by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,>,1,1,>,MIC90,ug.mL-1,8.0,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,MIC90,ug ml-1,UO_0000274,8.0
44497,,5171754,CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC,ug ml-1,UO_0000274,0.06
44498,,5171756,CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,<=,1,1,<=,MIC,ug.mL-1,0.004,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC,ug ml-1,UO_0000274,0.004
44499,Not Active,5171762,CHEMBL1667338,Antibacterial activity against Neisseria meningitidis assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,Activity,,,
44500,,5171768,CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC50,ug ml-1,UO_0000274,0.008
44501,,5171774,CHEMBL1665414,Antibacterial activity against Neisseria meningitidis by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.008,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,MIC90,ug ml-1,UO_0000274,0.008
44502,,5171785,CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC,ug ml-1,UO_0000274,0.06
44503,,5171792,CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
44504,,5171799,CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
44505,,5171806,CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC,ug ml-1,UO_0000274,0.06
44506,,5171813,CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.03
44507,,5171820,CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,0.5
44508,,5171827,CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC50,ug ml-1,UO_0000274,0.25
44509,,5171834,CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC50,ug ml-1,UO_0000274,0.25
44510,,5171841,CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,2.0
44511,,5171848,CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC50,ug ml-1,UO_0000274,64.0
44512,,5171855,CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC50,ug ml-1,UO_0000274,0.25
44513,,5171862,CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,0.5
44514,,5171869,CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC50,ug ml-1,UO_0000274,8.0
44515,,5171876,CHEMBL1665415,Antibacterial activity against Proteus mirabilis by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,MIC90,ug ml-1,UO_0000274,16.0
44516,,5171883,CHEMBL1665416,Antibacterial activity against Proteus vulgaris by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,MIC90,ug ml-1,UO_0000274,0.5
44517,,5171890,CHEMBL1665417,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,4.0
44518,,5171897,CHEMBL1666088,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,>,1,1,>,MIC90,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,128.0
44519,,5171904,CHEMBL1667015,Antibacterial activity against Serratia marcescens by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,MIC90,ug ml-1,UO_0000274,1.0
44520,,5171911,CHEMBL1667016,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,1.0
44521,,5171918,CHEMBL1667345,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia by CLSI M7-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC90,ug ml-1,UO_0000274,32.0
44522,,5171925,CHEMBL1667339,Antibacterial activity against Proteus mirabilis assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,62.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,62.0
44523,,5171932,CHEMBL1667340,Antibacterial activity against Proteus vulgaris assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,Activity,%,UO_0000187,100.0
44524,Not Active,5171939,CHEMBL1667341,Antibacterial activity against ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
44525,Not Active,5171946,CHEMBL1667342,Antibacterial activity against non-ciprofloxacin-susceptible Pseudomonas aeruginosa assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,,,
44526,,5171953,CHEMBL1667343,Antibacterial activity against levofloxacin susceptible Serratia marcescens assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,98.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,Activity,%,UO_0000187,98.0
44527,Not Active,5171960,CHEMBL1667344,Antibacterial activity against non-levofloxacin susceptible Stenotrophomonas maltophilia assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,,,
44528,Not Active,5171967,CHEMBL1667346,Antibacterial activity against levofloxacin-susceptible Stenotrophomonas maltophilia assessed as assessed as percent susceptible isolates by CLSI M7-A7 method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1327194,,1,0,,Activity,,,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,,,
44529,,5171974,CHEMBL1667017,Antibacterial activity against Bacteroides fragilis by CLSI M11-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,0.25
44530,,5171979,CHEMBL1667018,Antibacterial activity against Clostridium perfringens by CLSI M11-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,ug ml-1,UO_0000274,0.25
44531,,5171984,CHEMBL1667019,Antibacterial activity against Fusobacterium sp. by CLSI M11-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,MIC,ug ml-1,UO_0000274,0.25
44532,,5171989,CHEMBL1667020,Antibacterial activity against Peptostreptococcus sp. by CLSI M11-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,MIC,ug ml-1,UO_0000274,0.25
44533,,5171994,CHEMBL1667021,Antibacterial activity against Prevotella sp. by CLSI M11-A7 method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.12
44534,,5171999,CHEMBL1667022,Antibacterial activity against Propionibacterium acnes by CLSI M11-A7 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC,ug ml-1,UO_0000274,0.25
44535,,5172004,CHEMBL1667023,Antibacterial activity against Bacteroides fragilis assessed as percent susceptible isolates by CLSI M11-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,95.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,%,UO_0000187,95.0
44536,,5172009,CHEMBL1667024,Antibacterial activity against Clostridium perfringens assessed as percent susceptible isolates by CLSI M11-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,Activity,%,UO_0000187,100.0
44537,,5172014,CHEMBL1667166,Antibacterial activity against Fusobacterium sp. assessed as percent susceptible isolates by CLSI M11-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,95.2,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,Activity,%,UO_0000187,95.2
44538,,5172019,CHEMBL1667167,Antibacterial activity against Peptostreptococcus sp. assessed as percent susceptible isolates by CLSI M11-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,98.1,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,Activity,%,UO_0000187,98.1
44539,,5172024,CHEMBL1667168,Antibacterial activity against Prevotella sp. assessed as percent susceptible isolates by CLSI M11-A7 method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,45.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,45.0
44540,,5172029,CHEMBL1667169,Antibacterial activity against Propionibacterium acnes assessed as percent susceptible isolates by CLSI M11-A7 method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1327194,=,1,0,=,Activity,%,100.0,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,Activity,%,UO_0000187,100.0
44541,,5172034,CHEMBL1667017,Antibacterial activity against Bacteroides fragilis by CLSI M11-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC50,ug ml-1,UO_0000274,0.5
44542,,5172039,CHEMBL1667018,Antibacterial activity against Clostridium perfringens by CLSI M11-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC50,ug ml-1,UO_0000274,0.5
44543,,5172044,CHEMBL1667019,Antibacterial activity against Fusobacterium sp. by CLSI M11-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,MIC50,ug ml-1,UO_0000274,1.0
44544,,5172049,CHEMBL1667020,Antibacterial activity against Peptostreptococcus sp. by CLSI M11-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,MIC50,ug ml-1,UO_0000274,0.25
44545,,5172054,CHEMBL1667021,Antibacterial activity against Prevotella sp. by CLSI M11-A7 method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,4.0
44546,,5172059,CHEMBL1667022,Antibacterial activity against Propionibacterium acnes by CLSI M11-A7 method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC50,ug ml-1,UO_0000274,0.25
44547,,5172064,CHEMBL1667017,Antibacterial activity against Bacteroides fragilis by CLSI M11-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,2.0
44548,,5172069,CHEMBL1667018,Antibacterial activity against Clostridium perfringens by CLSI M11-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,ug ml-1,UO_0000274,0.5
44549,,5172074,CHEMBL1667019,Antibacterial activity against Fusobacterium sp. by CLSI M11-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612690,Fusobacterium sp.,Fusobacterium sp.,68766.0,,MIC90,ug ml-1,UO_0000274,2.0
44550,,5172079,CHEMBL1667020,Antibacterial activity against Peptostreptococcus sp. by CLSI M11-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614616,Peptostreptococcus sp.,Peptostreptococcus sp.,1262.0,,MIC90,ug ml-1,UO_0000274,0.5
44551,,5172084,CHEMBL1667021,Antibacterial activity against Prevotella sp. by CLSI M11-A7 method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,8.0
44552,,5173109,CHEMBL1667022,Antibacterial activity against Propionibacterium acnes by CLSI M11-A7 method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649565,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327194,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,MIC90,ug ml-1,UO_0000274,0.25
44553,,5173153,CHEMBL1667371,Antimicrobial activity against Salmonella enterica serovar Typhimurium STYM61/9 expressing qnrB19 gene variant carried by IncL/M-like plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649567,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321827,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.5
44554,,5173159,CHEMBL1667372,Antimicrobial activity against Salmonella enterica serovar Typhimurium transconjugant p61/9T expressing qnrB19 gene variant carried by IncL/M-like plasmid by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649567,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321827,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.5
44555,,5173165,CHEMBL1667373,Antimicrobial activity against Escherichia coli CSH26RifR receiving qnrB19 gene variant carried by IncL/M-like plasmid from Salmonella enterica serovar Typhimurium STYM61/9 by Etest,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649567,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321827,=,1,1,=,MIC,ug.mL-1,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.047
44556,,5173710,CHEMBL1654669,Antimycobacterial activity against Mycobacterium tuberculosis 00-0715 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44557,,5173711,CHEMBL1654670,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 03-0738 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.25
44558,,5173712,CHEMBL1654671,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2934 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.25
44559,,5173713,CHEMBL1654672,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-1647 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44560,,5173714,CHEMBL1654673,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0930 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44561,,5173715,CHEMBL1654674,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0757 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,1.0
44562,,5173716,CHEMBL1652928,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0785 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44563,,5173717,CHEMBL1652929,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0790 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,1.0
44564,,5173718,CHEMBL1652930,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0791 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44565,,5173719,CHEMBL1652931,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0797 harboring gyrA Ala90Val mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,1.0
44566,,5173720,CHEMBL1652932,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 99-1914 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44567,,5173721,CHEMBL1652933,Antimycobacterial activity against Mycobacterium tuberculosis 02-1975 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44568,,5173722,CHEMBL1652934,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2614 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44569,,5173723,CHEMBL1652935,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2230 harboring gyrA Asp94Gly mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44570,,5173724,CHEMBL1652936,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0744 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,1.0
44571,,5173725,CHEMBL1652937,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0810 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44572,,5173726,CHEMBL1652938,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0821 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,4.0
44573,,5173727,CHEMBL1652939,Antimycobacterial activity against Mycobacterium tuberculosis 04-0649 harboring gyrA Asp94Asn mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,4.0
44574,,5173728,CHEMBL1652940,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2399 harboring gyrA Asp94Tyr mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44575,,5173729,CHEMBL1652941,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-0319 harboring gyrA Asp94Ala mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44576,,5173730,CHEMBL1652942,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0172 harboring gyrA Asp94Ala mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44577,,5173731,CHEMBL1652943,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 04-0519 harboring gyrA Ala90Val and Asp94Asn mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,>,1,1,>,MIC,ug.mL-1,8.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,8.0
44578,,5173732,CHEMBL1652944,Antimycobacterial activity against Mycobacterium tuberculosis 08-0787 harboring gyrA Asp94His mutant gene and deletion of codons 678 and 679 in gyrB mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44579,,5173733,CHEMBL1652945,Antimycobacterial activity against Mycobacterium tuberculosis 08-0745 harboring gyrA Asp89Asn mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,2.0
44580,,5173734,CHEMBL1652946,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-1234 harboring gyrA Asn533Thr gyrB mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.5
44581,,5173735,CHEMBL1652947,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2834 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,1.0
44582,,5173736,CHEMBL1652948,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0794 harboring gyrA Thr80Ala mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44583,,5173737,CHEMBL1652949,Antimycobacterial activity against Mycobacterium tuberculosis 08-0815 harboring gyrA Thr80Ala and Ala90Gly mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44584,,5173738,CHEMBL1652950,Antimycobacterial activity against Mycobacterium tuberculosis 08-0773 harboring gyrA Pro8Ala mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44585,,5173739,CHEMBL1652951,Antimycobacterial activity against Mycobacterium tuberculosis 08-0769 harboring gyrA putative promoter mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44586,,5173740,CHEMBL1652952,Antimycobacterial activity against Mycobacterium tuberculosis 08-0771 harboring gyrA putative promoter mutant gene by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44587,,5173741,CHEMBL1653052,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0746 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44588,,5173742,CHEMBL1653053,Antimycobacterial activity against Mycobacterium tuberculosis 08-0762 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44589,,5173743,CHEMBL1653054,Antimycobacterial activity against Mycobacterium tuberculosis 08-0764 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44590,,5173744,CHEMBL1653055,Antimycobacterial activity against Mycobacterium tuberculosis 08-0774 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44591,,5173745,CHEMBL1653056,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0777 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44592,,5173746,CHEMBL1653057,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0779 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44593,,5173747,CHEMBL1653058,Antimycobacterial activity against Mycobacterium tuberculosis 08-0781 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44594,,5173748,CHEMBL1653059,Antimycobacterial activity against Mycobacterium tuberculosis 08-0782 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44595,,5173749,CHEMBL1653060,Antimycobacterial activity against Mycobacterium tuberculosis 08-0789 by resazurin microtiter assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322463,<=,1,1,<=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.125
44596,Not Active,5173750,CHEMBL1653061,Antimycobacterial activity against Mycobacterium tuberculosis 00-0715 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44597,Not Active,5173751,CHEMBL1653062,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 03-0738 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44598,Not Active,5173752,CHEMBL1653063,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2934 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44599,Not Active,5173753,CHEMBL1653064,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-1647 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44600,Not Active,5173754,CHEMBL1653065,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0930 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44601,Not Active,5173755,CHEMBL1653066,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0757 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44602,Not Active,5173756,CHEMBL1653067,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0785 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44603,Not Active,5173757,CHEMBL1653068,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0790 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44604,Not Active,5173758,CHEMBL1653069,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0791 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44605,Not Active,5173759,CHEMBL1653070,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0797 harboring gyrA Ala90Val mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44606,Not Active,5173760,CHEMBL1653071,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 99-1914 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44607,Not Active,5173761,CHEMBL1653072,Antimycobacterial activity against Mycobacterium tuberculosis 02-1975 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44608,Not Active,5173762,CHEMBL1653073,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2614 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44609,Not Active,5173763,CHEMBL1653074,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2230 harboring gyrA Asp94Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44610,Not Active,5173764,CHEMBL1653075,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0744 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44611,Not Active,5173765,CHEMBL1653076,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0810 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44612,Not Active,5173766,CHEMBL1653077,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0821 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44613,Not Active,5173767,CHEMBL1653078,Antimycobacterial activity against Mycobacterium tuberculosis 04-0649 harboring gyrA Asp94Asn mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44614,Not Active,5173768,CHEMBL1653079,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-2399 harboring gyrA Asp94Tyr mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44615,Not Active,5173769,CHEMBL1654163,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-0319 harboring gyrA Asp94Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44616,Not Active,5173770,CHEMBL1654164,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-0172 harboring gyrA Asp94Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44617,Not Active,5173771,CHEMBL1654165,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 04-0519 harboring gyrA Ala90Val and Asp94Asn mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44618,Not Active,5173772,CHEMBL1654166,Antimycobacterial activity against Mycobacterium tuberculosis 08-0787 harboring gyrA Asp94His mutant gene assessed as microbial susceptibility and deletion of codons 678 and 679 in gyrB mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44619,Not Active,5173773,CHEMBL1654167,Antimycobacterial activity against Mycobacterium tuberculosis 08-0745 harboring gyrA Asp89Asn mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44620,Not Active,5173774,CHEMBL1654168,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 02-1234 harboring gyrA Asn533Thr gyrB mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44621,Not Active,5173775,CHEMBL1654169,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 01-2834 by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44622,Active,5173776,CHEMBL1654170,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0794 harboring gyrA Thr80Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44623,Active,5173777,CHEMBL1654171,Antimycobacterial activity against Mycobacterium tuberculosis 08-0815 harboring gyrA Thr80Ala and Ala90Gly mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44624,Active,5173778,CHEMBL1654172,Antimycobacterial activity against Mycobacterium tuberculosis 08-0773 harboring gyrA Pro8Ala mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44625,Active,5173779,CHEMBL1654173,Antimycobacterial activity against Mycobacterium tuberculosis 08-0769 harboring gyrA putative promoter mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44626,Active,5173780,CHEMBL1654174,Antimycobacterial activity against Mycobacterium tuberculosis 08-0771 harboring gyrA putative promoter mutant gene assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44627,Active,5173781,CHEMBL1654175,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0746 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44628,Active,5173782,CHEMBL1654176,Antimycobacterial activity against Mycobacterium tuberculosis 08-0762 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44629,Active,5173783,CHEMBL1654177,Antimycobacterial activity against Mycobacterium tuberculosis 08-0764 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44630,Active,5173784,CHEMBL1654178,Antimycobacterial activity against Mycobacterium tuberculosis 08-0774 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44631,Active,5173785,CHEMBL1654179,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0777 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44632,Active,5173786,CHEMBL1654180,Antimycobacterial activity against multidrug-resistant Mycobacterium tuberculosis 08-0779 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44633,Active,5173787,CHEMBL1654181,Antimycobacterial activity against Mycobacterium tuberculosis 08-0781 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44634,Active,5173788,CHEMBL1654182,Antimycobacterial activity against Mycobacterium tuberculosis 08-0782 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44635,Active,5173789,CHEMBL1654183,Antimycobacterial activity against Mycobacterium tuberculosis 08-0789 assessed as microbial susceptibility by agar proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649247,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1322463,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44636,,5175304,CHEMBL1653188,Antibacterial activity against Staphylococcus aureus SMH36633 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.03
44637,,5175305,CHEMBL1653189,Antibacterial activity against Staphylococcus aureus SMH37099 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.03
44638,,5175306,CHEMBL1653190,Antibacterial activity against Staphylococcus aureus SMH37312 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.03
44639,,5175307,CHEMBL1653191,Antibacterial activity against Staphylococcus aureus SMH37390 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.04
44640,,5175308,CHEMBL1653192,Antibacterial activity against Staphylococcus aureus SMH37503 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.05
44641,,5175309,CHEMBL1653193,Antibacterial activity against Staphylococcus aureus SMH38002 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.05
44642,,5175310,CHEMBL1653194,Antibacterial activity against Staphylococcus aureus SMH38004 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.09,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.09
44643,,5175311,CHEMBL1653195,Antibacterial activity against Staphylococcus aureus SMH37276 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,0.7
44644,,5175312,CHEMBL1653196,Antibacterial activity against Staphylococcus aureus SMH36742 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,1.0
44645,,5175313,CHEMBL1653197,Antibacterial activity against Staphylococcus aureus SMH36945 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323371,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,mg/L,UO_0000274,2.0
44646,,5175314,CHEMBL1653198,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH36633,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,53.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,53.7
44647,,5175315,CHEMBL1653199,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH37099,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,41.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,41.7
44648,,5175316,CHEMBL1653200,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH37312,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,18.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,18.6
44649,,5175317,CHEMBL1653201,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH37390,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,12.0
44650,,5175318,CHEMBL1653202,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH37503,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,20.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,20.4
44651,,5175319,CHEMBL1653203,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH38002,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,16.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,16.6
44652,,5175320,CHEMBL1653329,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH38004,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,8.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,8.7
44653,,5175321,CHEMBL1653330,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH37276,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,30.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,30.2
44654,,5175322,CHEMBL1653331,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH36742,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,19.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,19.5
44655,,5175323,CHEMBL1653332,Ratio of AUC (0 to 24 hrs) to MIC required for 24 hrs bacteriostatic effect in Staphylococcus aureus SMH36945,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,42.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,42.7
44656,,5175324,CHEMBL1653333,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH36633,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,61.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,61.7
44657,,5175325,CHEMBL1653334,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH37099,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,49.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,49.0
44658,,5175326,CHEMBL1653335,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH37312,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,22.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,22.4
44659,,5175327,CHEMBL1653336,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH37390,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,15.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,15.1
44660,,5175328,CHEMBL1653337,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH37503,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,30.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,30.2
44661,,5175329,CHEMBL1653338,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH38002,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,19.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,19.1
44662,,5175330,CHEMBL1653981,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH38004,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,19.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,19.5
44663,,5175331,CHEMBL1653982,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH37276,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,43.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,43.7
44664,,5175332,CHEMBL1653983,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH36742,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,20.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,20.9
44665,,5175333,CHEMBL1653984,Ratio of AUC (0 to 24 hrs) to MIC required for 1-log drop in bacterial count in Staphylococcus aureus SMH36945,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,52.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,52.7
44666,,5175334,CHEMBL1653985,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH36633,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,70.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,70.8
44667,,5175335,CHEMBL1653986,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH37099,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,56.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,56.2
44668,,5175336,CHEMBL1653987,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH37312,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,26.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,26.3
44669,,5175337,CHEMBL1653988,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH37390,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,18.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,18.6
44670,,5175338,CHEMBL1653989,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH37503,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,45.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,45.7
44671,,5175339,CHEMBL1653990,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH38002,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,21.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,21.4
44672,,5175340,CHEMBL1653991,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH38004,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,41.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,41.7
44673,,5175341,CHEMBL1653992,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH37276,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,64.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,64.6
44674,,5175342,CHEMBL1653993,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH36742,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,23.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,23.4
44675,,5175343,CHEMBL1653994,Ratio of AUC (0 to 24 hrs) to MIC required for 2-log drop in bacterial count in Staphylococcus aureus SMH36945,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,89.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,89.1
44676,,5175344,CHEMBL1653995,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH36633,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,83.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,83.2
44677,,5175345,CHEMBL1653996,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH37099,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,67.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,67.6
44678,,5175346,CHEMBL1653997,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH37312,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,30.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,30.9
44679,,5175347,CHEMBL1653998,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH37390,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,25.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,25.1
44680,,5175348,CHEMBL1654117,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH37503,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,85.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,85.1
44681,,5175349,CHEMBL1654118,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH38002,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,25.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,25.1
44682,,5175350,CHEMBL1654119,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH38004,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,95.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,95.5
44683,,5175351,CHEMBL1654120,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH37276,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,120.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,120.0
44684,,5175352,CHEMBL1654121,Ratio of AUC (0 to 24 hrs) to MIC required for 3-log drop in bacterial count in Staphylococcus aureus SMH36742,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649300,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323371,=,1,0,=,RatioAUC/MIC,,25.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,RatioAUC/MIC,,,25.4
44685,,5175508,CHEMBL1655091,Antimicrobial activity against Clostridium difficile ATCC 43603 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44686,,5175509,CHEMBL1655090,Antimicrobial activity against Clostridium difficile ATCC 43603-M1 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,64.0
44687,,5175510,CHEMBL1655089,Antimicrobial activity against Clostridium difficile CD196 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,2.0
44688,,5175511,CHEMBL1655092,Antimicrobial activity against Clostridium difficile CD196 M1 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,128.0
44689,,5175512,CHEMBL1655093,Antimicrobial activity against Clostridium difficile CD07-259 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44690,,5175513,CHEMBL1655094,Antimicrobial activity against Clostridium difficile 6269 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,8.0
44691,,5175514,CHEMBL1655095,Antimicrobial activity against Clostridium difficile 6425 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323384,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,32.0
44692,,5175516,CHEMBL1655105,Upregulation of cwp84 gene expression in Clostridium difficile CD196 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,7.1,CHEMBL612546,,Molecular identity unknown,,,FC,,,7.1
44693,,5175518,CHEMBL1655106,Upregulation of slpA gene expression in Clostridium difficile CD196 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,1.8,CHEMBL612546,,Molecular identity unknown,,,FC,,,1.8
44694,,5175520,CHEMBL1655107,Upregulation of fbp68 gene expression in Clostridium difficile CD196 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,5.0,CHEMBL612546,,Molecular identity unknown,,,FC,,,5.0
44695,,5175522,CHEMBL1655108,Upregulation of cwp84 gene expression in Clostridium difficile CD196 M1 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,2.9,CHEMBL612546,,Molecular identity unknown,,,FC,,,2.9
44696,,5175524,CHEMBL1655109,Upregulation of slpA gene expression in Clostridium difficile CD196 M1 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,1.9,CHEMBL612546,,Molecular identity unknown,,,FC,,,1.9
44697,,5175526,CHEMBL1654527,Upregulation of fbp68 gene expression in Clostridium difficile CD196 M1 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,1.1,CHEMBL612546,,Molecular identity unknown,,,FC,,,1.1
44698,,5175528,CHEMBL1653374,Upregulation of cwp84 gene expression in Clostridium difficile ATCC 43603 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,3.1,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,3.1
44699,,5175530,CHEMBL1653375,Upregulation of slpA gene expression in Clostridium difficile ATCC 43603 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,2.9,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,2.9
44700,,5175532,CHEMBL1653376,Upregulation of fbp68 gene expression in Clostridium difficile ATCC 43603 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,2.1,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,2.1
44701,,5175534,CHEMBL1653377,Upregulation of cwp84 gene expression in Clostridium difficile ATCC 43603-M1 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,17.3,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,17.3
44702,,5175536,CHEMBL1653378,Upregulation of slpA gene expression in Clostridium difficile ATCC 43603-M1 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,16.5,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,16.5
44703,,5175538,CHEMBL1653379,Upregulation of fbp68 gene expression in Clostridium difficile ATCC 43603-M1 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,0.8,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,0.8
44704,,5175540,CHEMBL1653380,Induction of Cwp84 protease expression in Clostridium difficile 6425 at 0.5 times MIC by immunoblot analysis,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1323384,=,1,0,=,Activity,%,130.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,%,UO_0000187,130.0
44705,Active,5175542,CHEMBL1653381,Induction of Cwp84 protease expression in Clostridium difficile CD196 at 0.5 times MIC by immunoblot analysis,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44706,Active,5175544,CHEMBL1653382,Induction of Cwp84 protease expression in Clostridium difficile CD196 M1 at 0.5 times MIC by immunoblot analysis,F,BAO_0000375,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44707,,5175546,CHEMBL1653383,Induction of Cwp84 protease expression in Clostridium difficile ATCC 43603-M1 at 0.5 times MIC by immunoblot analysis,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1323384,=,1,0,=,Activity,%,20.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,%,UO_0000187,20.0
44708,Not Active,5175548,CHEMBL1653384,Effect on Cwp84 protease expression in Clostridium difficile ATCC 43603 at 0.5 times MIC by immunoblot analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44709,Active,5175550,CHEMBL1653385,Induction of Cwp84 protease expression in Clostridium difficile 6269 at 0.5 times MIC by immunoblot analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44710,Active,5176625,CHEMBL1653386,Induction of Cwp84 protease expression in Clostridium difficile CD07-259 at 0.5 times MIC by immunoblot analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44711,,5176628,CHEMBL1655096,Upregulation of slpA gene expression in Clostridium difficile 6425 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,4.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,4.0
44712,,5176629,CHEMBL1655097,Upregulation of slpA gene expression in Clostridium difficile CD07-259 at 0.5 times MIC by real-time PCR analysis relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,=,1,0,=,FC,,14.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,FC,,,14.0
44713,Active,5176633,CHEMBL1655098,Upregulation of slpA gene expression in Clostridium difficile 6269 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44714,Active,5176637,CHEMBL1655099,Upregulation of cwp84 gene expression in Clostridium difficile 6425 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44715,Active,5176641,CHEMBL1655100,Upregulation of cwp84 gene expression in Clostridium difficile CD07-259 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44716,Active,5176645,CHEMBL1655101,Upregulation of cwp84 gene expression in Clostridium difficile 6269 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44717,Not Active,5176649,CHEMBL1655102,Effect on fbp69 gene expression in Clostridium difficile 6425 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44718,Not Active,5176653,CHEMBL1655103,Effect on fbp69 gene expression in Clostridium difficile CD07-259 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44719,Not Active,5176657,CHEMBL1655104,Effect on fbp69 gene expression in Clostridium difficile 6269 at 0.5 times MIC by real-time PCR analysis,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649303,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1323384,,1,0,,Activity,,,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,,,
44720,,5179125,CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322824,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.06
44721,,5179134,CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322824,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC50,ug ml-1,UO_0000274,0.06
44722,,5179143,CHEMBL1660014,Antimicrobial activity against Mycoplasma pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322824,=,1,1,=,MIC90,ug.mL-1,0.12,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC90,ug ml-1,UO_0000274,0.12
44723,,5179152,CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322824,=,1,1,=,MIC,ug.mL-1,0.063,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC,ug ml-1,UO_0000274,0.063
44724,,5179159,CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322824,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC50,ug ml-1,UO_0000274,0.06
44725,,5179166,CHEMBL1660015,Antimicrobial activity against Mycoplasma hominis by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649263,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322824,=,1,1,=,MIC90,ug.mL-1,0.06,CHEMBL615053,Metamycoplasma hominis,Metamycoplasma hominis,2098.0,,MIC90,ug ml-1,UO_0000274,0.06
44726,,5179193,CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44727,,5179204,CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC50,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug/L,UO_0000274,0.063
44728,,5179215,CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC90,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug/L,UO_0000274,0.125
44729,,5179226,CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,3.1e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.031
44730,,5179237,CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC50,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug/L,UO_0000274,0.063
44731,,5179248,CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC90,ug.mL-1,0.000125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug/L,UO_0000274,0.125
44732,,5179259,CHEMBL1660034,Antibacterial activity against Mycoplasma genitalium G37 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44733,,5179270,CHEMBL1660035,Antibacterial activity against Mycoplasma genitalium M30 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44734,,5179281,CHEMBL1660036,Antibacterial activity against Mycoplasma genitalium R32 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44735,,5179292,CHEMBL1660037,Antibacterial activity against Mycoplasma genitalium TW10-5G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44736,,5179303,CHEMBL1660038,Antibacterial activity against Mycoplasma genitalium TW10-6G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44737,,5179314,CHEMBL1660039,Antibacterial activity against Mycoplasma genitalium TW48-5G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44738,,5179325,CHEMBL1660040,Antibacterial activity against Mycoplasma genitalium UTMB-10G by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.063
44739,,5179336,CHEMBL1660041,Antibacterial activity against Mycoplasma genitalium M2282 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44740,,5179347,CHEMBL1660042,Antibacterial activity against Mycoplasma genitalium M2300 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44741,,5179358,CHEMBL1660043,Antibacterial activity against Mycoplasma genitalium M2321 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44742,,5179369,CHEMBL1660044,Antibacterial activity against Mycoplasma genitalium M2341 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44743,,5179380,CHEMBL1660045,Antibacterial activity against Mycoplasma genitalium M6257 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44744,,5179391,CHEMBL1660046,Antibacterial activity against Mycoplasma genitalium M6280 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44745,,5179402,CHEMBL1660047,Antibacterial activity against Mycoplasma genitalium M6285 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44746,,5179413,CHEMBL1660048,Antibacterial activity against Mycoplasma genitalium M6286 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44747,,5179424,CHEMBL1660173,Antibacterial activity against Mycoplasma genitalium M6328 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44748,,5180478,CHEMBL1660174,Antibacterial activity against Mycoplasma genitalium M6090 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44749,,5180489,CHEMBL1660175,Antibacterial activity against Mycoplasma genitalium M6151 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44750,,5180500,CHEMBL1660176,Antibacterial activity against Mycoplasma genitalium M6282 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44751,,5180511,CHEMBL1660177,Antibacterial activity against Mycoplasma genitalium M6283 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44752,,5180522,CHEMBL1660178,Antibacterial activity against Mycoplasma genitalium M6284 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44753,,5180533,CHEMBL1660179,Antibacterial activity against Mycoplasma genitalium M6287 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649265,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322837,=,1,1,=,MIC,ug.mL-1,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug/L,UO_0000274,0.016
44754,,5186025,CHEMBL1653953,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
44755,,5186034,CHEMBL1653955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
44756,,5186043,CHEMBL1653957,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.12
44757,,5186052,CHEMBL1653959,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
44758,,5186061,CHEMBL1653961,Antimicrobial activity against Coagulase-negative Staphylococcus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.12
44759,,5186070,CHEMBL1653963,Antimicrobial activity against Group A Streptococcus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC,ug ml-1,UO_0000274,0.25
44760,,5186079,CHEMBL1653965,Antimicrobial activity against Group B Streptococcus by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC,ug ml-1,UO_0000274,0.25
44761,,5186088,CHEMBL1653967,Antimicrobial activity against Group C Streptococcus by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
44762,,5186097,CHEMBL1653969,Antimicrobial activity against Group G Streptococcus by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
44763,,5186106,CHEMBL1653971,Antimicrobial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.12
44764,,5186115,CHEMBL1653973,Antimicrobial activity against Corynebacterium spp. by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,MIC,ug ml-1,UO_0000274,0.25
44765,,5186124,CHEMBL1653975,Antimicrobial activity against Listeria monocytogenes by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC,ug ml-1,UO_0000274,0.5
44766,,5186133,CHEMBL1653977,Antimicrobial activity against Streptococcus mitis by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC,ug ml-1,UO_0000274,0.12
44767,,5186142,CHEMBL1653953,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.12
44768,,5186151,CHEMBL1653955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
44769,,5186160,CHEMBL1653957,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
44770,,5186169,CHEMBL1653959,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
44771,,5186178,CHEMBL1653961,Antimicrobial activity against Coagulase-negative Staphylococcus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.25
44772,,5186187,CHEMBL1653963,Antimicrobial activity against Group A Streptococcus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC50,ug ml-1,UO_0000274,0.25
44773,,5186196,CHEMBL1653965,Antimicrobial activity against Group B Streptococcus by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC50,ug ml-1,UO_0000274,0.25
44774,,5186205,CHEMBL1653967,Antimicrobial activity against Group C Streptococcus by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.25
44775,,5186214,CHEMBL1653969,Antimicrobial activity against Group G Streptococcus by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,0.25
44776,,5186223,CHEMBL1653971,Antimicrobial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
44777,,5186232,CHEMBL1653973,Antimicrobial activity against Corynebacterium spp. by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL613081,Corynebacterium sp.,Corynebacterium sp.,1720.0,,MIC50,ug ml-1,UO_0000274,1.0
44778,,5186241,CHEMBL1653975,Antimicrobial activity against Listeria monocytogenes by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,MIC50,ug ml-1,UO_0000274,0.5
44779,,5186250,CHEMBL1653977,Antimicrobial activity against Streptococcus mitis by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,MIC50,ug ml-1,UO_0000274,0.25
44780,,5186259,CHEMBL1653953,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.25
44781,,5186268,CHEMBL1653955,Antimicrobial activity against methicillin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
44782,,5186277,CHEMBL1653957,Antimicrobial activity against Heterovancomycin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,4.0
44783,,5186286,CHEMBL1653959,Antimicrobial activity against vancomycin-resistant Staphylococcus aureus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,8.0
44784,,5186295,CHEMBL1653961,Antimicrobial activity against Coagulase-negative Staphylococcus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,8.0
44785,,5186304,CHEMBL1653963,Antimicrobial activity against Group A Streptococcus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL612389,Streptococcus sp. 'group A',Streptococcus sp. 'group A',36470.0,,MIC90,ug ml-1,UO_0000274,0.5
44786,,5186313,CHEMBL1653965,Antimicrobial activity against Group B Streptococcus by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613186,Streptococcus sp. 'group B',Streptococcus sp. 'group B',1319.0,,MIC90,ug ml-1,UO_0000274,0.5
44787,,5186322,CHEMBL1653967,Antimicrobial activity against Group C Streptococcus by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
44788,,5186331,CHEMBL1653969,Antimicrobial activity against Group G Streptococcus by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,0.5
44789,,5186340,CHEMBL1653971,Antimicrobial activity against Streptococcus pneumoniae by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1649269,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322882,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
44790,,5212089,CHEMBL1678630,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus SH1000 by CLSI broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332644,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.0625
44791,Not Determined,5212094,CHEMBL1678631,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by CLSI broth microdilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332644,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
44792,,5212102,CHEMBL1678617,Half life in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 400 mg every 24 hrs,A,BAO_0002115,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1332644,=,1,1,=,T1/2,hr,12.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,t1/2,hr,UO_0000032,12.13
44793,,5212103,CHEMBL1678616,AUC (0 to 24 hrs) in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 400 mg every 24 hrs,A,BAO_0002120,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332644,=,1,1,=,AUC,ng.hr.mL-1,44150.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,AUC,ug/ml.hr,,44.15
44794,,5212119,CHEMBL1678637,Bactericidal activity against Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in planktonic cell count at 400 mg every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332644,=,1,0,=,log10CFU/ml,,2.33,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,2.33
44795,,5212120,CHEMBL1678636,Bactericidal activity against Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in biofilm bacterial count at 400 mg every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332644,=,1,0,=,log10CFU/ml,,2.38,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,2.38
44796,,5212121,CHEMBL1678635,Bactericidal activity against Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in planktonic cell count at 400 mg every 24 hrs measured after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332644,=,1,0,=,log10CFU/ml,,4.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,4.04
44797,,5212122,CHEMBL1678634,Bactericidal activity against Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model assessed as decrease in biofilm bacterial count at 400 mg every 24 hrs measured after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332644,=,1,0,=,log10CFU/ml,,4.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,4.06
44798,Not Active,5212325,CHEMBL1673527,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2301 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332672,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44799,Not Active,5212335,CHEMBL1673521,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2403 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332672,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44800,Not Active,5212344,CHEMBL1675242,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 761 obtained from pus of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332672,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44801,Not Active,5212354,CHEMBL1675236,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 625 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332672,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44802,Not Active,5212364,CHEMBL1673533,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2911 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332672,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44803,,5213264,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44804,,5213265,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44805,,5213266,CHEMBL1676498,Antimicrobial activity against Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44806,,5213267,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44807,,5213268,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44808,,5213269,CHEMBL1676499,Antimicrobial activity against Streptococcus pneumoniae serotype 3 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44809,,5213270,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44810,,5213271,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44811,,5213272,CHEMBL1676500,Antimicrobial activity against Streptococcus pneumoniae serotype 35B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44812,,5213273,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44813,,5213274,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44814,,5213275,CHEMBL1676501,Antimicrobial activity against Streptococcus pneumoniae serotype 7F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44815,,5213276,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44816,,5213277,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44817,,5213278,CHEMBL1676618,Antimicrobial activity against Streptococcus pneumoniae serotype 11A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44818,,5213279,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44819,,5213280,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44820,,5213281,CHEMBL1676619,Antimicrobial activity against Streptococcus pneumoniae serotype 6C by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44821,,5213282,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44822,,5213283,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44823,,5213284,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44824,,5213285,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44825,,5213286,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC50,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.5
44826,,5213287,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44827,,5213293,CHEMBL1676620,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44828,,5213294,CHEMBL1676621,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44829,,5213295,CHEMBL1676622,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332161,<=,1,1,<=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44830,Not Determined,5213399,CHEMBL1673539,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2474 obtained from sputum of patient at 2 ug/ml by Bactec MGIT960 modified proportion method,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332672,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
44831,,5213405,CHEMBL1673548,Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis H37Rv by CLSI method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332672,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.125
44832,,5213415,CHEMBL1673547,"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2911 horboring rpoB D516V, katG S315T/R463L, gyrA D94G/S95T/R128S/Y129C, rrs A1401G by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332672,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
44833,,5213416,CHEMBL1673543,"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 625 horboring rpoB S531L/G566R/I569L, katG S315T/R463L, gyrA A90V/S95T, rrs A1401G by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332672,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
44834,,5213417,CHEMBL1673546,"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2474 horboring rpoB H526Y, katG D329A/R463L, gyrA D94G/S95T, rrs A1401G by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332672,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
44835,,5213418,CHEMBL1673544,"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 761 horboring rpoB S531L/Q510P, katG S315T/R463L, gyrA D94N/S95T, rrs G1484T by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332672,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
44836,,5213420,CHEMBL1673545,"Antimycobacterial activity against extensively drug-resistant Mycobacterium tuberculosis isolate 2301 horboring rpoB S531L, katG R463L/E217G, gyrA D94N/S95T, rrs A1401G by CLSI method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671750,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332672,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
44837,,5214449,CHEMBL1677043,Antimicrobial activity against Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44838,,5214460,CHEMBL1677044,Antimicrobial activity against Streptococcus pneumoniae serotype 3 assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44839,,5214471,CHEMBL1677045,Antimicrobial activity against Streptococcus pneumoniae serotype 35B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44840,,5214482,CHEMBL1677046,Antimicrobial activity against Streptococcus pneumoniae serotype 7F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44841,,5214494,CHEMBL1677047,Antimicrobial activity against Streptococcus pneumoniae serotype 11A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44842,,5214506,CHEMBL1677048,Antimicrobial activity against Streptococcus pneumoniae serotype 6C assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44843,,5214518,CHEMBL1677049,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
44844,,5214530,CHEMBL1677050,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
44845,,5214542,CHEMBL1677051,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae serotype 6B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,99.2,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.2
44846,,5214589,CHEMBL1677175,Antimicrobial activity against Streptococcus pneumoniae serotype 15A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44847,,5214590,CHEMBL1677176,Antimicrobial activity against Streptococcus pneumoniae serotype 22F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44848,,5214591,CHEMBL1677179,Antimicrobial activity against Streptococcus pneumoniae serotype 23A assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
44849,,5214592,CHEMBL1677177,Antimicrobial activity against Streptococcus pneumoniae serotype 23B assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,97.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,97.0
44850,,5214593,CHEMBL1677178,Antimicrobial activity against Streptococcus pneumoniae serotype 19F assessed as percent susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671689,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332161,=,1,0,=,Activity,%,96.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,96.6
44851,,5214795,CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,32.0
44852,,5214796,CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.5
44853,,5214810,CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,>,1,1,>,MIC50,ug.mL-1,32.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC50,ug ml-1,UO_0000274,32.0
44854,,5214811,CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC50,ug ml-1,UO_0000274,2.0
44855,,5214825,CHEMBL1676704,Antibacterial activity against 10'4 to 10'5 CFU Moraxella catarrhalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,>,1,1,>,MIC90,ug.mL-1,32.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC90,ug ml-1,UO_0000274,32.0
44856,,5214826,CHEMBL1676703,Antibacterial activity against 10'4 to 10'5 CFU Haemophilus influenzae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC90,ug ml-1,UO_0000274,8.0
44857,,5217671,CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
44858,,5217679,CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,0.06
44859,,5217687,CHEMBL1677448,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,0.125
44860,,5217695,CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
44861,,5217703,CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.03
44862,,5217711,CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC,ug ml-1,UO_0000274,0.06
44863,,5217719,CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44864,,5217727,CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,4.0
44865,,5217735,CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,0.125
44866,,5217743,CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC50,ug ml-1,UO_0000274,2.0
44867,,5217751,CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
44868,,5217759,CHEMBL1677447,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant Staphylococcus aureus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC90,ug ml-1,UO_0000274,64.0
44869,,5217767,CHEMBL1676711,Antibacterial activity against 10'4 to 10'5 CFU methicillin-susceptible coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,4.0
44870,,5217775,CHEMBL1676709,Antibacterial activity against 10'4 to 10'5 CFU methicillin-resistant coagulase-negative Staphylococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612624,Staphylococcus,Staphylococcus,1279.0,,MIC90,ug ml-1,UO_0000274,8.0
44871,,5217783,CHEMBL1676710,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pneumoniae after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.5
44872,,5217791,CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.125
44873,,5217799,CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.06
44874,,5217807,CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.25
44875,,5217815,CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC,ug ml-1,UO_0000274,0.25
44876,,5217823,CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC50,ug ml-1,UO_0000274,0.125
44877,,5217831,CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC50,ug ml-1,UO_0000274,1.0
44878,,5217839,CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,4.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC50,ug ml-1,UO_0000274,4.0
44879,,5217847,CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC50,ug ml-1,UO_0000274,2.0
44880,,5217855,CHEMBL1676708,Antibacterial activity against 10'4 to 10'5 CFU Streptococcus pyogenes after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC90,ug ml-1,UO_0000274,0.25
44881,,5217863,CHEMBL1676707,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecalis after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC90,ug ml-1,UO_0000274,32.0
44882,,5217871,CHEMBL1676706,Antibacterial activity against 10'4 to 10'5 CFU Enterococcus faecium after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC90,ug ml-1,UO_0000274,32.0
44883,,5217879,CHEMBL1676705,Antibacterial activity against 10'4 to 10'5 CFU vancomycin-resistant Enterococcus after 18 hrs by CLSI 2-fold agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671764,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332735,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,MIC90,ug ml-1,UO_0000274,4.0
44884,,5220016,CHEMBL1675894,Antimicrobial activity against Clostridium perfringens after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,ug ml-1,UO_0000274,0.25
44885,,5220026,CHEMBL1675892,Antimicrobial activity against Finegoldia magna assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,27.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,Activity,%,UO_0000187,27.0
44886,,5220036,CHEMBL1675890,Antimicrobial activity against Finegoldia magna assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,60.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,Activity,%,UO_0000187,60.0
44887,,5220046,CHEMBL1675888,Antimicrobial activity against Finegoldia magna after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC,ug ml-1,UO_0000274,0.13
44888,,5220056,CHEMBL1675886,Antimicrobial activity against Peptoniphilus asaccharolyticus assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,Activity,%,UO_0000187,0.0
44889,,5220066,CHEMBL1675884,Antimicrobial activity against Peptoniphilus asaccharolyticus assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,100.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,Activity,%,UO_0000187,100.0
44890,,5220076,CHEMBL1675882,Antimicrobial activity against Peptoniphilus asaccharolyticus after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC,ug ml-1,UO_0000274,0.13
44891,,5220086,CHEMBL1675880,Antimicrobial activity against Anaerococcus prevotii assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,13.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,Activity,%,UO_0000187,13.0
44892,,5220096,CHEMBL1675878,Antimicrobial activity against Anaerococcus prevotii assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,87.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,Activity,%,UO_0000187,87.0
44893,,5220106,CHEMBL1675876,Antimicrobial activity against Anaerococcus prevotii after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC,ug ml-1,UO_0000274,0.06
44894,,5220116,CHEMBL1675874,Antimicrobial activity against Peptostreptococcus micros assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,8.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,Activity,%,UO_0000187,8.0
44895,,5220126,CHEMBL1675872,Antimicrobial activity against Peptostreptococcus micros assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,8.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,Activity,%,UO_0000187,8.0
44896,,5220136,CHEMBL1675870,Antimicrobial activity against Peptostreptococcus anaerobius assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,Activity,%,UO_0000187,92.0
44897,,5220146,CHEMBL1675868,Antimicrobial activity against Peptostreptococcus anaerobius assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,Activity,%,UO_0000187,92.0
44898,,5220156,CHEMBL1675730,Antimicrobial activity against Peptostreptococcus micros after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC,ug ml-1,UO_0000274,0.06
44899,,5220166,CHEMBL1675728,Antimicrobial activity against Peptostreptococcus anaerobius after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,0.06
44900,,5220176,CHEMBL1675048,Antimicrobial activity against Prevotella oralis after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,MIC90,ug ml-1,UO_0000274,8.0
44901,,5220186,CHEMBL1675046,Antimicrobial activity against Prevotella buccae after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC90,ug ml-1,UO_0000274,8.0
44902,,5220196,CHEMBL1674935,Antimicrobial activity against Prevotella bivia after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC90,ug ml-1,UO_0000274,8.0
44903,,5220206,CHEMBL1674933,Antimicrobial activity against Prevotella intermedia after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC90,ug ml-1,UO_0000274,0.5
44904,,5220216,CHEMBL1675048,Antimicrobial activity against Prevotella oralis after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,MIC50,ug ml-1,UO_0000274,2.0
44905,,5220226,CHEMBL1675046,Antimicrobial activity against Prevotella buccae after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC50,ug ml-1,UO_0000274,2.0
44906,,5220236,CHEMBL1674935,Antimicrobial activity against Prevotella bivia after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC50,ug ml-1,UO_0000274,2.0
44907,,5220246,CHEMBL1674933,Antimicrobial activity against Prevotella intermedia after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC50,ug ml-1,UO_0000274,0.5
44908,,5220256,CHEMBL1675726,Antimicrobial activity against Fusobacterium mortiferum after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC,ug ml-1,UO_0000274,0.25
44909,,5220266,CHEMBL1675724,Antimicrobial activity against Fusobacterium nucleatum after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC,ug ml-1,UO_0000274,0.25
44910,,5220276,CHEMBL1675722,Antimicrobial activity against Fusobacterium necrogenes after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.25
44911,,5220699,CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,0.25
44912,,5220713,CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,0.5
44913,,5220727,CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC50,ug ml-1,UO_0000274,0.5
44914,,5220741,CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC50,ug ml-1,UO_0000274,1.0
44915,,5220755,CHEMBL1675182,Antibacterial activity against Bacteroides fragilis by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,2.0
44916,,5220769,CHEMBL1675185,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC90,ug ml-1,UO_0000274,4.0
44917,,5220782,CHEMBL1673466,Antibacterial activity against Bacteroides fragilis assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,90.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,%,UO_0000187,90.0
44918,,5220793,CHEMBL1673467,Antibacterial activity against Bacteroides fragilis assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,7.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,%,UO_0000187,7.0
44919,,5220808,CHEMBL1673472,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,87.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,Activity,%,UO_0000187,87.0
44920,,5220819,CHEMBL1673473,Antibacterial activity against beta-lactamase producing Bacteroides thetaiotaomicron assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,7.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,Activity,%,UO_0000187,7.0
44921,,5220835,CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC,ug ml-1,UO_0000274,0.25
44922,,5220847,CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC50,ug ml-1,UO_0000274,0.5
44923,,5220859,CHEMBL1673478,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC90,ug ml-1,UO_0000274,2.0
44924,,5220870,CHEMBL1673479,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,91.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,Activity,%,UO_0000187,91.0
44925,,5220881,CHEMBL1673480,Antibacterial activity against beta-lactamase producing Bacteroides vulgatus assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,9.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,Activity,%,UO_0000187,9.0
44926,,5220903,CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC,ug ml-1,UO_0000274,0.25
44927,,5220915,CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC50,ug ml-1,UO_0000274,0.5
44928,,5220927,CHEMBL1673762,Antibacterial activity against beta-lactamase producing Bacteroides uniformis by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,MIC90,ug ml-1,UO_0000274,2.0
44929,,5220938,CHEMBL1673763,Antibacterial activity against beta-lactamase producing Bacteroides uniformis assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,91.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,Activity,%,UO_0000187,91.0
44930,,5220949,CHEMBL1673764,Antibacterial activity against beta-lactamase producing Bacteroides uniformis assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,9.0,CHEMBL612622,Bacteroides uniformis,Bacteroides uniformis,820.0,,Activity,%,UO_0000187,9.0
44931,,5220971,CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC,ug ml-1,UO_0000274,0.25
44932,,5220983,CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC50,ug ml-1,UO_0000274,0.5
44933,,5220995,CHEMBL1673771,Antibacterial activity against beta-lactamase producing Bacteroides caccae by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC90,ug ml-1,UO_0000274,2.0
44934,,5221006,CHEMBL1673772,Antibacterial activity against beta-lactamase producing Bacteroides caccae assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,91.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,Activity,%,UO_0000187,91.0
44935,,5221249,CHEMBL1679009,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 49951 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332007,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
44936,,5221257,CHEMBL1679010,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332007,<=,1,1,<=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
44937,,5221265,CHEMBL1679011,Antimicrobial activity against methicillin-resistant Staphylococcus aureus NB01021 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332007,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
44938,,5221273,CHEMBL1679012,Antimicrobial activity against Streptococcus pneumoniae ATCC 6301 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332007,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44939,,5221281,CHEMBL1679013,Antimicrobial activity against Streptococcus pneumoniae ATCC 6303 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332007,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
44940,,5221289,CHEMBL1679014,Antimicrobial activity against multiple drug-resistant Streptococcus pneumoniae ATCC 700677 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332007,<=,1,1,<=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
44941,,5221330,CHEMBL1674318,Antimicrobial activity against Streptococcus pneumoniae ATCC 6303 infected in po dosed BALB/c mouse pneumonia model assessed as complete eradication of bacteria administered twice daily 3 days starting 16 hrs post infection,F,BAO_0003036,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332007,=,1,1,=,ED50,mg.kg-1,14.3,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,ED50,mg kg-1,UO_0000308,14.3
44942,,5221350,CHEMBL1675720,Antimicrobial activity against Fusobacterium varium after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC,ug ml-1,UO_0000274,0.25
44943,,5221360,CHEMBL1675718,Antimicrobial activity against Porphyromonas asaccharolytica after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL615058,Porphyromonas asaccharolytica,Porphyromonas asaccharolytica,28123.0,,MIC,ug ml-1,UO_0000274,0.25
44944,,5221370,CHEMBL1675716,Antimicrobial activity against Prevotella oralis assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,11.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,Activity,%,UO_0000187,11.0
44945,,5221380,CHEMBL1675714,Antimicrobial activity against Prevotella oralis assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,56.0,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,Activity,%,UO_0000187,56.0
44946,,5221390,CHEMBL1675712,Antimicrobial activity against Prevotella buccae assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,11.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,Activity,%,UO_0000187,11.0
44947,,5221400,CHEMBL1675058,Antimicrobial activity against Prevotella buccae assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,56.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,Activity,%,UO_0000187,56.0
44948,,5221410,CHEMBL1675056,Antimicrobial activity against Prevotella bivia assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,11.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,Activity,%,UO_0000187,11.0
44949,,5221420,CHEMBL1675054,Antimicrobial activity against Prevotella bivia assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,56.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,Activity,%,UO_0000187,56.0
44950,,5221430,CHEMBL1675052,Antimicrobial activity against Prevotella intermedia assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,Activity,%,UO_0000187,0.0
44951,,5221440,CHEMBL1675050,Antimicrobial activity against Prevotella intermedia assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,100.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,Activity,%,UO_0000187,100.0
44952,,5221450,CHEMBL1675048,Antimicrobial activity against Prevotella oralis after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612687,Hoylesella oralis,Hoylesella oralis,28134.0,,MIC,ug ml-1,UO_0000274,0.5
44953,,5221460,CHEMBL1675046,Antimicrobial activity against Prevotella buccae after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC,ug ml-1,UO_0000274,0.5
44954,,5221470,CHEMBL1674935,Antimicrobial activity against Prevotella bivia after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC,ug ml-1,UO_0000274,0.5
44955,,5221480,CHEMBL1674933,Antimicrobial activity against Prevotella intermedia after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC,ug ml-1,UO_0000274,0.5
44956,,5221489,CHEMBL1674931,Antimicrobial activity against Bacteroides ovatus assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,18.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,Activity,%,UO_0000187,18.0
44957,,5221495,CHEMBL1674907,Antimicrobial activity against Bacteroides ovatus after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC90,ug ml-1,UO_0000274,16.0
44958,,5221505,CHEMBL1674905,Antimicrobial activity against Bacteroides vulgatus after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC90,ug ml-1,UO_0000274,16.0
44959,,5221511,CHEMBL1675900,Antimicrobial activity against Clostridium difficile after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,32.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC90,ug ml-1,UO_0000274,32.0
44960,,5221520,CHEMBL1675900,Antimicrobial activity against Clostridium difficile after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,16.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC50,ug ml-1,UO_0000274,16.0
44961,,5221530,CHEMBL1675894,Antimicrobial activity against Clostridium perfringens after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,ug ml-1,UO_0000274,0.5
44962,,5221540,CHEMBL1675894,Antimicrobial activity against Clostridium perfringens after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC50,ug ml-1,UO_0000274,0.5
44963,,5221550,CHEMBL1675888,Antimicrobial activity against Finegoldia magna after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC90,ug ml-1,UO_0000274,8.0
44964,,5221560,CHEMBL1675888,Antimicrobial activity against Finegoldia magna after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC50,ug ml-1,UO_0000274,0.5
44965,,5221570,CHEMBL1675882,Antimicrobial activity against Peptoniphilus asaccharolyticus after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC90,ug ml-1,UO_0000274,2.0
44966,,5221580,CHEMBL1675882,Antimicrobial activity against Peptoniphilus asaccharolyticus after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC50,ug ml-1,UO_0000274,0.25
44967,,5221590,CHEMBL1675876,Antimicrobial activity against Anaerococcus prevotii after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC90,ug ml-1,UO_0000274,8.0
44968,,5221600,CHEMBL1675876,Antimicrobial activity against Anaerococcus prevotii after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612351,Anaerococcus prevotii,Anaerococcus prevotii,33034.0,,MIC50,ug ml-1,UO_0000274,0.25
44969,,5221610,CHEMBL1675730,Antimicrobial activity against Peptostreptococcus micros after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC90,ug ml-1,UO_0000274,0.25
44970,,5221620,CHEMBL1675728,Antimicrobial activity against Peptostreptococcus anaerobius after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,0.25,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,0.25
44971,,5221630,CHEMBL1675730,Antimicrobial activity against Peptostreptococcus micros after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC50,ug ml-1,UO_0000274,0.125
44972,,5221640,CHEMBL1675728,Antimicrobial activity against Peptostreptococcus anaerobius after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.125,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,0.125
44973,,5221649,CHEMBL1675904,Antimicrobial activity against Clostridium difficile assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,75.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,%,UO_0000187,75.0
44974,,5221658,CHEMBL1675902,Antimicrobial activity against Clostridium difficile assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,25.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,Activity,%,UO_0000187,25.0
44975,,5221667,CHEMBL1675900,Antimicrobial activity against Clostridium difficile after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614965,Clostridioides difficile,Clostridioides difficile,1496.0,,MIC,ug ml-1,UO_0000274,1.0
44976,,5221677,CHEMBL1675898,Antimicrobial activity against Clostridium perfringens assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,7.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,Activity,%,UO_0000187,7.0
44977,,5221687,CHEMBL1675896,Antimicrobial activity against Clostridium perfringens assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,93.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,Activity,%,UO_0000187,93.0
44978,,5222062,CHEMBL1673773,Antibacterial activity against beta-lactamase producing Bacteroides caccae assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,9.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,Activity,%,UO_0000187,9.0
44979,,5222084,CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC,ug ml-1,UO_0000274,0.06
44980,,5222096,CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC,ug ml-1,UO_0000274,0.06
44981,,5222108,CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC,ug ml-1,UO_0000274,0.06
44982,,5222120,CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC,ug ml-1,UO_0000274,0.06
44983,,5222132,CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC50,ug ml-1,UO_0000274,1.0
44984,,5222144,CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC50,ug ml-1,UO_0000274,1.0
44985,,5222156,CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC50,ug ml-1,UO_0000274,1.0
44986,,5222168,CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC50,ug ml-1,UO_0000274,1.0
44987,,5222180,CHEMBL1673780,Antibacterial activity against Fusobacterium varium by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,MIC90,ug ml-1,UO_0000274,4.0
44988,,5222192,CHEMBL1673781,Antibacterial activity against Fusobacterium nucleatum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,MIC90,ug ml-1,UO_0000274,4.0
44989,,5222204,CHEMBL1673782,Antibacterial activity against Fusobacterium mortiferum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,MIC90,ug ml-1,UO_0000274,4.0
44990,,5222216,CHEMBL1673783,Antibacterial activity against Fusobacterium necrophorum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,MIC90,ug ml-1,UO_0000274,4.0
44991,,5222227,CHEMBL1673784,Antibacterial activity against Fusobacterium varium assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,81.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,Activity,%,UO_0000187,81.0
44992,,5222238,CHEMBL1673785,Antibacterial activity against Fusobacterium nucleatum assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,81.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,Activity,%,UO_0000187,81.0
44993,,5222249,CHEMBL1673786,Antibacterial activity against Fusobacterium mortiferum assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,81.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,Activity,%,UO_0000187,81.0
44994,,5222260,CHEMBL1673787,Antibacterial activity against Fusobacterium necrophorum assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,81.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,Activity,%,UO_0000187,81.0
44995,,5222271,CHEMBL1673788,Antibacterial activity against Fusobacterium varium assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL614416,Fusobacterium varium,Fusobacterium varium,856.0,,Activity,%,UO_0000187,0.0
44996,,5222282,CHEMBL1673789,Antibacterial activity against Fusobacterium nucleatum assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL614609,Fusobacterium nucleatum,Fusobacterium nucleatum,851.0,,Activity,%,UO_0000187,0.0
44997,,5222293,CHEMBL1673790,Antibacterial activity against Fusobacterium mortiferum assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL614415,Fusobacterium mortiferum,Fusobacterium mortiferum,850.0,,Activity,%,UO_0000187,0.0
44998,,5222304,CHEMBL1673791,Antibacterial activity against Fusobacterium necrophorum assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL614417,Fusobacterium necrophorum,Fusobacterium necrophorum,859.0,,Activity,%,UO_0000187,0.0
44999,,5222356,CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC,ug ml-1,UO_0000274,0.25
